Post on 11-Jun-2020
ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ
Δρ. ΔΗΜΗΤΡΙΟΣ Π. ΜΠΟΓΔΑΝΟΣ
ΕΠΙΚΟΥΡΟΣ ΚΑΘΗΓΗΤΗΣ ΠΑΘΟΛΟΓΙΑΣ
ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ, ΣΧΟΛΕΣ ΕΠΙΣΤΗΜΩΝ ΥΓΙΕΙΑΣ, ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ
ΝΟΕΜΒΡΙΟΣ 2015
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
2
ΠΡΟΣΩΠΙΚΑ ΣΤΟΙΧΕΙΑ ΟΝΟΜΑΤΕΠΩΝΥΜΟ
ΟΝΟΜΑ ΠΑΤΕΡΑ
ΟΝΟΜΑ ΜΗΤΕΡΑΣ
ΗΜΕΡΟΜΗΝΙΑ ΓΕΝΝΗΣΗΣ
ΕΘΝΙΚΟΤΗΤΑ
ΟΙΚΟΓΕΝΕΙΑΚΗ ΚΑΤΑΣΤΑΣΗ
ΕΠΑΓΓΕΛΜΑΤΙΚΗ ΔΙΕΥΘΥΝΣΗ
TΗΛ. ΕΠΙΚΟΙΝΩΝΙΑΣ
ΗΛΕΚΤΡΟΝΙΚΟ ΤΑΧΥΔΡΟΜΕΙΟ
ΔΙΕΥΘΥΝΣΗ ΚΑΤΟΙΚΙΑΣ
ΔΗΜΗΤΡΙΟΣ Π. ΜΠΟΓΔΑΝΟΣ
ΠΕΤΡΟΣ
ΑΝΑΣΤΑΣΙΑ
18Η ΣΕΠΤΕΜΒΡΙΟΥ 1968
ΕΛΛΗΝΙΚΗ
ΕΓΓΑΜΟΣ, ΠΑΤΕΡΑΣ ΕΝΟΣ ΠΑΙΔΙΟΥ
ΡΕΥΜΑΤΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ
ΤΜΗΜΑ ΙΑΤΡΙΚΗΣ, ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ
ΥΓΙΕΙΑΣ, ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΙΑΣ
ΠΑΝΕΠΙΣΤΗΜΙΑΚΟ ΓΕΝΙΚΟ ΝΟΣ. ΛΑΡΙΣΑΣ
ΤΗΛ: 241 350 2766
ΚΙΝΗΤΟ: 6938 606 510
bogdanos@med.uth.gr
ΡΟΔΟΥ 55,
ΛΑΡΙΣΑ, 41447
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
3
ΣΤΑΔΙΟΔΡΟΜΙΑ - ΘΕΣΕΙΣ ΙΟΥΛΙΟΣ 1997 Πτυχίο Ιατρικής, Αριστοτέλειο Πανεπιστήμιο
Θεσσαλονίκης
ΦΕΒΡΟΥΑΡΙΟΣ 1998
Άδεια άσκησης ιατρικού επαγγέλματος, Διεύθυνση Υγιεινής, Νομαρχιακή Αυτοδιοίκηση Βοιωτίας, (ΑΔ. 8110/03-02-98)
ΦΕΒΡΟΥΑΡΙΟΣ 1998
Μέλος του Ιατρικού Συλλόγου Λιβαδειάς, Βοιωτίας (03-02-08)
ΦΕΒΡΟΥΑΡΙΟΣ 1998
Πλήρες Μέλος, General Medical Council, Great Britain (RN:4488787/26-2-98)
ΑΠΡΙΛΙΟΣ 1998 - ΜΑΡΤΙΟΣ 2001
Ειδικευόμενος Ιατρός (House Officer & Senior House Officer Grade, NHS), Department of Internal Medicine, University College London Medical School & Hospitals, London (Director: Professor Roger Williams)
ΑΠΡΙΛΙΟΣ 2001 – ΟΚΤΩΒΡΙΟΣ 2001
Επισκέπτης Επιστημονικός Συνεργάτης (Sir Yule Bogue Visiting Research Scientist), Diabetes Group, Department of Endocrinology, Division of Internal Medicine, Yale School of Medicine (Head: Professor Li Wen)
NΟΕΜΒΡΙΟΣ 2001 - ΔΕΚΕΜΒΡΙΟΣ 2002
Ειδικευόμενος Ιατρός (Registrar Grade, NHS), Department of Internal Medicine, University College London Medical School & Hospitals, London (Director: Professor Roger Williams)
ΜΑΡΤΙΟΣ 1998-ΔΕΚΕΜΒΡΙΟΣ 2002
Επιστημονικός Συνεργάτης Κλινικής Έρευνας (Clinical Research Fellow) Institute of Hepatology, Royal Free and University College London Medical School & Hospitals (Head: Professor Diego Vergani)
ΙΑΝΟΥΑΡΙΟΣ 2003 – ΜΑΙΟΣ 2005
Ειδικευόμενος Ιατρός (Registrar Grade, NHS), King’s College Hospital, London (Director: Professor Giorgina Mieli-Vergani)
ΙΑΝΟΥΑΡΙΟΣ 2003 – ΔΕΚΕΜΒΡΙΟΣ 2006
Κύριος Ερευνητής (Principal Investigator), Alex Mowat Laboratory, Institute of Liver Studies, King’s College London School of Medicine at King’s College Hospital (Head: Professor Diego Vergani)
ΜΑΙΟΣ 2005
Διδάκτωρ (Doctor of Philosphophy-PhD Medicine), University of London
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
4
ΑΠΡΙΛΙΟΣ 2006 Completion of Specialist Training Certificate in Internal Medicine (710/06-04-2006 & 102462/30-08-06)
ΜΑΙΟΣ 2006
Αναγνώριση ισοτιμίας PhD από το ΔΟΑΤΑΠ (10-682/18-05-06)
ΙΟΥΝΙΟΣ 2006
Βραβείο CSL AWARDEE, Higher Education Funding Council of England (HEFCE), KING’S COLLEGE LONDON
ΙΟΥΛΙΟΣ 2006
Μετακαλούμενος Ερευνητής ΓΓΕΤ ΕΝΤΕΡ 2004 (EP82)
ΙΑΝΟΥΑΡΙΟΣ 2007 Τίτλος Ιατρικής Ειδικότητας Παθολογίας (Νομαρχιακή Αυτοδιοίκηση Ιωαννίνων, Αρ. Πρωτ. 7442/ 10-01-2007)
ΦΕΒΡΟΥΑΡΙΟΣ 2007
Πλήρες Μέλος/GMC Specialist in Internal Medicine (RN: 4488787)
ΜΑΙΟΣ 2007– 2011 Διευθυντής (Consultant Physician), Liver Unit, King’s College Hospital (General Medical Director: Professor Moxham) Επίκουρος Καθηγητής (Senior Clinical Lecturer), Division of Gene and Cell Based Therapy, Institute of Liver Studies, King’s College London School of Medicine at King’s College Hospital (Head of Division: Professor Swee Lay Thein) Υπεύθυνος Ειδικού Εξωτερικού Ηπατολογικού Ιατρείου (Primary Biliary Cirrhosis-Liver Outpatient Clinic) Συμμετοχή στο Ειδικό Εξωτερικό Ηπατολογικού Ιατρείου (Abnormal Liver Function Tests Clinic-Liver Outpatient Clinic) (Από το 2010 –Σεπ 2011)
ΣΕΠΤΕΜΒΡΙΟΣ 2011- ΟΚΤΩΒΡΙΟΣ 2013
Επίκουρος Καθηγητής Παθολογίας, Τομέας Παθολογίας, Τμήμα Ιατρικής, Σχολές Υγείας, Πανεπιστήμιο Θεσσαλίας Επισκέπτης Καθηγητής Ανοσοπαθολογίας, Division of Transplantation Immunology and Mucosal Biology, King’s College London School of Medicine at King’s College Hospital (Head of Division: Professor David Sacks) (Από τον Ιανουάριο του 2012)
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
5
ΤΙΤΛΟΙ ΣΠΟΥΔΩΝ
Ι. Απολυτήριο Λυκείου (2ο Λύκειο Λιβαδειάς Βοιωτίας, 19/09/86)
ΙΙ. Πτυχίο της Ιατρικής Σχολής, Αριστοτέλειo Πανεπιστήμιο Θεσσαλονίκης
(18/07/97)
ΙΙΙ. Διδάκτωρ, University College London School of Medicine (31/05/06)
ΑΔΕΙΑ ΑΣΚΗΣΗΣ ΙΑΤΡΙΚΟΥ ΕΠΑΓΓΕΛΜΑΤΟΣ Ι. Άδεια άσκησης Ιατρικού Επαγγέλματος στην Ελλάδα (8110/03-02-98)
ΙΙ. Άδεια άσκησης Ιατρικού Επαγγέλματος στη Μεγάλη Βρετανία
(GMC:4488787/26-02-98)
ΙΙΙ. Τίτλος Αναγνώρισης Ειδικότητας Παθολογίας στην Ελλάδα (7442 /10-01-07)
ΙV. Τίτλος Αναγνώρισης Ειδικότητας Παθολογίας (Internal Medicine) στη Μεγάλη Βρετανία (GMC:4488787/13-02-07)
ΤΙΜΗΤΙΚΕΣ ΔΙΑΚΡΙΣΕΙΣ - ΒΡΑΒΕΙΑ Ιούνιος 2006
HEFCE CLS Award Το βραβείο αυτό του Higher Education Funding Council for England (HEFCE) δόθηκε για πρώτη φορά σε Έλληνα ιατρό. Το Συμβούλιο τίμησε το πρωτότυπο ερευνητικό έργο στο τομέα της παθογένειας της πρωτοπαθούς χολικής κίρρωσης και συνοδεύτηκε από χρηματικό έπαθλο ₤500.000.
Σεπτέμβριος 2004
Dame Sheila Sherlock Research Medal της Βρετανικής Εταιρείας Μελέτης του Ήπατος (British Association for the Study of the Liver, BASL), Σεπτέμβριος 2004. Το Μετάλιο απονέμεται στον κορυφαίο Ερευνητή – Μέλος της Εταιρείας της χρονιάς και δόθηκε για πρώτη φορά σε Έλληνα ιατρό και γενικότερα σε ιατρό μη-Βρετανικής καταγωγής.
EASL Sheila
Sherlock Post-Doc
Level Fellowship
Award 2012
Επιβλέπων Κύριος Ερευνητής της Dr Vasiliki Gkretsi για την ερευνητική εργασία με τίτλο “The role of integrin-proximal protein complexesduring hepatocellular carcinoma metastasis” (www.easl.eu).
EASL Sheila
Sherlock Short
Visting Fellowship
Award 2011
Επιβλέπων Ερευνητής (Κύριος Ερευνητής Professor Andrew K. Burroughs, Royal Free Hospital, London) της Dr Rania Romanidou για την ερευνητική εργασία με τίτλο ‘E. coli infection in primary biliary cirrhosis: is there any link?’
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
6
Alex Mowat 2010
Investigator’s
Award
Στην προδιδακτορική PhD φοιτήτριά μου, Dr Mytilinaiou δόθηκε από κοινού το 1st Prize για τη μελέτη ‘Investigating the role of molecular mimicry and epitope spreading as mechanisms responsible for the development of antigen-specific immune responses in patients with autoimmune hepatitis’.
EASL Sheila
Sherlock Post-doc
Fellowship Award
2008
Επιβλέπων Ερευνητής του Dr Athanasios Mavropoulos για τη μελέτη ‘The role of p38 MAPK in the pathogenesis of autoimmune hepatitis’. Dr Athanasios Mavropoulos is an immunobiologist and post-doc researcher.
EASL Sheila
Sherlock Entry-level
Fellowship Award
2005
Επιβλέπων Ερευνητής της Dr Francesca Meda: ‘B and T cell epitope mapping of the nuclear pore P62-Specific responses in patients with primary biliary cirrhosis’ .
November 2010 Presidential Distinction, AASLD 2010 (στην Dr Maria Mytilinaiou & Dr Bogdanos)
April 2010 1st Prize, Alex Mowat Biennial Meeting (London) (στην Dr Maria Mytilinaiou & Dr Bogdanos)
April 2007 Mentorship, Leventis Foundation (Paris) PhD Award (support στην Dr Maria Mytilinaiou)
April 2008
Mentorship, Leventis Foundation (Paris) PhD Award (για την υποστήριξη του Dr Elias Spyrou)
Travel Bursary Awards για εμένα ή ερευνητές της
ερευνητικής ομάδας:
May 2011 Travel Bursary Award, 44th ESPGHAN Annual Congress, Sorrento, Italy
April 2011 Travel Bursary Award, 46th Liver International Congress, European Association for the Study of Liver (EASL), Berlin
April 2010 Travel Bursary Award, 45th Liver International Congress, EASL, Vienna
April 2009 Travel Bursary Award, 44th Liver International Congress, EASL, Copenhagen
April 2008 Travel Bursary Award, 43rd Liver International Congress, EASL, Milan
April 2007 Travel Bursary Award, 42nd Liver International Congress, EASL, Barcelona
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
7
April 2006 Travel Bursary Award, 41st Liver International Congress, EASL, Vienna
November 2004 Presidential Choice, 55th annual meeting, American Association for the Study of Liver Diseases (AASLD), Boston
October 2004 Investigator’s Award, 142nd Falk Symposium, Freiburg, Germany
September 2004 Best Oral Presentation, BASL annual meeting, Cambridge, UK
July 2004 Awarded Poster, 2nd World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN), Paris, France
April 2004 Travel Bursary Award, 43rd Liver International Congress, European Association for the Study of Liver (EASL), Milan
April 2004 Investigator’s Award, 5th Biennial Alex Mowat Meeting
April 2003 Best Poster Award, European Association for the Study of the Liver (EASL), Geneva, Switzerland
October 2003 Investigator’s Award, 136th Falk Symposium, Freiburg, Germany
September 2000,
2001, 2003
BASL Travel Bursary Award
April 2001
Sir Bogue Visiting Research Fellowship Award, University of
London (Host institution: Yale Medical School)
December 1999 Innovative Award (with Professor Vergani)-Multiple Sclerosis Society of Great Britain
October 1999 President’s Choice, 50th AASLD annual meeting, Dallas, USA
May 1997 1st prize, 1st European Medical Students’ Symposium, Crete, Greece
ΠΕΡΙΛΗΨΗ ΚΛΙΝΙΚΟΥ & ΑΚΑΔΗΜΑΙΚΟΥ ΕΡΓΟΥ
ΚΛΙΝΙΚΟ ΕΡΓΟ
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
8
Πανεπιστημιακή Ρευματολογική Κλινική (Διευθυντής: Καθηγητής Λάζαρος Σακκάς)
Υπεύθυνος για τη νοσηλεία των ασθενών της Ρευματολογικής Κλινινκής
Υπεύθυνος για τη νοσηλεία των ασθενών στη Μονάδα Ημερήσιας Νοσηλείας
Συμμετοχή σε Φαρμακευτικά Κλινικά Πρωτόκολλα (Clinical Trials)
Συζήτηση περιστατικών/παρακλινικές άλλων κλινικών
Το joint CSL contract (2007-2011) που είχα με το King’s College Hospital NHS Trust & το King’s College London Medical School περιελάμβανε 50% Κλινικό και 50% Ακαδημαικό Έργο (Clinical Director: Professor Nigel Heaton). Κατά τη διάρκεια της θητείας μου στο King’s College London School of Medicine ήμουν Μέλος του Συμβουλίου Διευθυντών της Μονάδας Ήπατος (Liver Consultants Committee), King’s College Ηospital, London Μέλος της Ομάδας Εργασίας Διευθυντών Ηπατολογίας (Η9), King’s College Ηospital, London Μέλος της Ομάδας Εργασίας Ηπατολογίας (Liver Group 2), King’s College Ηospital, London Μέλος της Επιτροπής Διοικητικής Μέριμνας Ήπατος – Νεφρών – Παγκρεάτος (Management Care Group – Renal/Liver/Pancreas), King’s College London Hospital
ΔΙΟΙΚΗΤΙΚΟ, ΣΥΜΒΟΥΛΕΥΤΙΚΟ & ΟΡΓΑΝΩΤΙΚΟ ΕΡΓΟ (2007- σήμερα)
Μέλος ΔΕΠ του Τομέα Παθολογίας, Τμήματος Ιατρικής, Σχολές Επιστημών
Υγείας (2011 έως σήμερα) ,
Επισκέπτης Καθηγητής. Division of Transplantation Immunology and Mucosal
Biology
Συνεργαζόμενο Μέλος ΔΕΠ στο Επιστημονικό Συμβούλιο της Τμήματος
Βιοιατρικής, Κέντρο Έρευνας & Τεχνολογίας θεσσαλίας
Κατά τη διάρκεια της θητείας μου στο King’s College London School of Medicine
ήμουν Μέλος της Ακαδημαϊκής Συντονιστικής Επιτροπής (Full Academic
Committee), Institute of Liver Studies, Division of Gene and Cell Based Therapy,
King’s College London Medical School at King’s College Hospital, London
Μέλος της Επιτροπής Μελών ΔΕΠ (HEFCE), Division of Gene and Cell Based
Therapy, King’s College London Medical School at King’s College Hospital,
London
Μέλος του Συμβουλίου Αυτοάνοσων Νοσημάτων Ήπατος, Institute of Liver
Studies, King’s College London Medical School at King’s College Hospital
Μέλος της Συντονιστικής Επιτροπής Πανεπιστημιακών Εργαστηρίων, Institute of
Liver Studies, King’s College London Medical School at King’s College Hospital
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
9
Μέλος της Γενικής Συνέλευσης Τμήματος Ιατρικής, Σχολή Υγείας, Π.Θ. (2013-
2014)
Μέλος της Γενικής Συνέλευσης Ειδικής Σύνθεσης Τμήματος Ιατρικής, Σχολή
Υγείας Π.Θ. (2013-2014)
Σύμβουλος Σπουδών ακαδημαικό έτος 2013-2014
Σύμβουλος Σπουδών ακαδημαικό έτος 2014-2015
Ενεργός συμμετοχή στη λειτουργία του Εργαστηρίου της Πανεπιστημιακής
Ρευματολογικής Κλινικής, Πανεπιστήμιο Θεσσαλίας (Διευθυντής: Καθηγητής Λάζαρος
Σακκάς)
Ενεργός συμμετοχή στη δημιουργία, οργάνωση και λειτουργία του Εργαστηρίου
Κυτταρικής Ανοσοθεραπείας και Μοριακής Ανοσοδιαγνωστικής, του οποίου είμαι και
υπεύθυνος στο Κέντρο Έρευνας και Τεχνολογίας Θεσσαλίας (Διευθυντής: Καθηγητής
Ηλίας Χούστης)
Είχα ενεργό συμμετοχή στην οργάνωση και λειτουργία του Εργαστηρίου
Ανοσοπαθολογίας (Director: Professor Diego Vergani), Institute of Liver Studies, King’s
College London School of Medicine (Ιανουάριος 2003- 2011)
Είχα ενεργό συμμετοχή στη δημιουργία, οργάνωση και λειτουργία του Εργαστηρίου
Ερευνητικής Παθολογίας, Ινστιτούτο Βιοιατρικής Έρευνας & Τεχνολογίας, Κέντρο
Έρευνας και Τεχνολογίας Θεσσαλίας, Γενική Γραμματεία Έρευνας και Τεχνολογίας
(Υπεύθυνος Καθηγητής: κ. Γεώργιος Νταλέκος)
Είχα ενεργό συμμετοχή στην αναδιοργάνωση και λειτουργία του Εργαστηρίου
Ανοσοπαθολογίας, Institute of Hepatology, University College London (Ιανουάριος 2001-
Δεκέμβριος 2002)
ΕΚΠΑΙΔΕΥΤΙΚΟ ΕΡΓΟ
Συμμετοχή στο εκπαιδευτικό πρόγραμμα μαθημάτων φοιτητών ιατρικής 3ΟΥ, 4ΟΥ και 6ΟΥ
Διαλέξεις από έδρας και φροντιστηριακά κλινικά μαθήματα
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
10
Μέχρι σήμερα έχω επιβλέψει:
4 post-doc PhD, 4 Mphil/PhD; 2 MSc; 3 MD φοιτητές; 19 Επισκέπτες –ριες ή
Επιστημονικούς Συνεργάτες –ριες
Τρέχουσα Επίβλεψη 2 Μεταπτυχιακών και 5 προπτυχιακών PhD φοιτητών/ριών , Π.Θ.
Εκπαίδευση προπτυχιακών & μεταπτυχιακών υποτρόφων του Πανεπιστημίου
Θεσσαλίας, τόσο στο Εργαστήριο της Πανεπιστημιακής Ρευματολογικής Κλινικής όσο
και σε συνεργασία με άλλα Εργαστήρια
Μετεκπαίδευση μεταπτυχιακών υποτρόφων, ειδικού τεχνολογικού και επιστημονικού
προσωπικού του Κέντρου Έρευνας και Τεχνολογίας Θεσσαλίας (Μάιος 2006 – εως
σήμερα)
Συμμετοχή με ομιλίες στα μετεκπαιδευτικά μαθήματα της Πανεπιστημιακής
Ρευματολογικής Κλινικής του Πανεπιστημίου Θεσσαλίας
Συμμετοχή με ομιλίες στα μετεκπαιδευτικά μαθήματα του Τμήματος Ανοσοπαθολογίας,
Institute of Liver Studies, King’s College London Medical School at King’s College
Hospital (Ακαδημαϊκά έτη 2003-εως σήμερα).
Υπεύθυνος (Modulator) των μετεκπαιδευτικών σεμιναρίων του Liver Immunopathology
Group, Institute of Liver Studies, King’s College London Medical School at King’s
College Hospital (Ακαδημαϊκά έτη 2003-εως 2011).
Mαθήματα Παθοφυσιολογίας στους φοιτητές του 1ου-3ου έτους της Iατρικής Σχολής του
University College London School of Medicine (Ακαδημαϊκά έτη 2001, 2002).
Συμμετοχή με ομιλίες στην εκπαίδευση φοιτητών και μετεκπαίδευση ειδικευομένων και
ειδικευμένων ιατρών, University College London School of Medicine and Hospitals
(Ακαδημαϊκά έτη 2001,2002) & King’s College London Medical School at King’s College
Hospital (Ακαδημαϊκά έτη 2003-εως 2011).
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
11
Συμμετοχή με ομιλίες στα μετεκπαιδευτικά μαθήματα των φοιτητών, ειδικευομένων και
ειδικευμένων ιατρών της Πανεπιστημιακής Ρευματολογικής Κλινικής, της
Πανεπιστημιακής Παθολογικής, της Πανεπιστημιακής Ογκολογικής και της
Πανεπιστημιακής Νεφρολογικής του Πανεπιστημίου Θεσσαλίας
Συμμετοχή με ομιλίες σε μετεκπαιδευτικά σεμινάρια μεταπτυχιακών υποτρόφων, ειδικών
επιστημόνων και ειδικευμένων ιατρών σε δίάφορα πανεπιστήμια και ερευνητικά κέντρα
στην Ελλάδα, Αγγλία, Γερμανία, Γαλλία, Ισπανία, ΗΠΑ, Ιταλία
ΜΕΛΟΣ ΟΜΑΔΩΝ ΣΥΝΤΑΞΗΣ -ΣΥΝΤΑΚΤΙΚΩΝ ΕΠΙΤΡΟΠΩΝ ΠΕΡΙΟΔΙΚΩΝ
1. Co-Editor-in-Chief: Innovation Immunology
2. Associate Editor: Meditteranean J Rheumatology – Ελληνική Ρευματολογία,
Autoimmunity Highlights, Archives of Medicine (Laboratory Medicine,
ολοκληρώθηκε το 2014), Annals of Gastroenterology (Basic Science),
ImmunoGastroenterology (Immunology), ολοκληρώθηκε το 2013),
3. Μέλος του Editorial Board: BMC Medicine, Autoimmunity Reviews, The
Scientific World Journal, World Journal of Rheumatology, BioMed Research
International, Open, Datasets, Journal of Clinical Immunology and
Immunopathological Research, The Open Journal of Pathology; The Open
Journal of Rheumatology; Open Journal of Rheumatology and Autoimmune
Diseases
ΕΠΙΣΤΗΜΟΝΙΚΟΣ ΚΡΙΤΗΣ (REVIEWER) ΣΤΑ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ
American Journal of Gastroenterology, Alimentary Pharmacology and Therapeutics,
Annals in Gastroenterology, Archives of Medical Science, Autoimmunity
Autoimmunity Reviews
Biomed Research International, BMC Gastroenterology, BMC Medicine,
Clinical Chemistry, Clinica Chimica Acta, Clinical and Developmental Immunology,
Clinical Experimental Immunology, Clinical Gastroenterology and Hepatology, Clinical
Infectious Diseases, Clinical Medicine Insights, Current Rheumatology Reviews,
Cytokine Research
Developmental and Comparative Immunology, Digestive and Liver Diseases, Dig Dis
Sciences
European J of Gastroenterology & Hepatology, Experimental Cell Research, , Expert
Reviews in Clinical Immunology, Expert Reviews in Gastroenterology and Hepatology
Gastroenterology, Gut
Hepatology
Immunology, ImmunoGastroenterology, Immunology Innovation, International
Journal of Immunopathology and Pharmacology
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
12
Journal of Autoimmune Diseases, Journal of Clinical Gastroenterology, Journal of
Clinical Immunology, Journal of Clinical Investigation, Journal of Clinical Pathology,
Journal of Hepatology, Journal of Immunology, Journal of Infectious Diseases
Liver International, Lupus
Medical Virology
Seminars in Liver Diseases, Steroids Biochemistry & Molecular Biology,
The Open Journal of Pathology, Toxins
ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΣΥΝΕΡΓΑΣΙΕΣ
USA: Professor M. Eric Gershwin (University of California at Davis, USA)
Professor Ditier Soll (Yale School of Medicine)
Canada: Professor Marvin Fritzler (University of Calgary)
Europe:
UK
Professor Diego Vergani (Κing’s College London)
Professor Giorgina Mieli-Vergani (King’s College London)
Professor Alastair Forbes (University College London & University of Norwich)
Germany:
Professor Ulrich Christen (University of Frankfurt);
Dr Jochen Mattner (Universität Erlangen-Nürnberg)
Professor Karsten Conrad (University of Dresden)
Professor Peter Schierack (University of Cottbus – Senftenberg)
Belgium: Professor Xavier Bossoyt (Univevrsity of Leuven)
Italy: Prof Nicola Bizzaro (University of Venice);
Associate Professors Pietro Invernizzi & Carlo Selmi (University of Milan);
Associate Professors Marco Lenzi & Luigi Muratori (University of Bologna)
Spain: Professor Albert Pares (University of Barcelona)
Turkey: Dr Cumali Efe (University of Ankara)
Poland: Professor Piotr Milkiewicz (Pomeranian Medical University, Szczecin)
Russia: Dr Sergey V Lapin (St. Petersburg Pavlov State Medical University)
Australia: Professor Ian R. Mackay (Monash University)
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
13
ΑΝΤΑΓΩΝΙΣΤΙΚΑ ΠΡΟΓΡΑΜΜΑΤΑ –ΧΡΗΜΑΤΙΚΑ ΒΡΑΒΕΙΑ – ΛΟΙΠΗ
ΧΡΗΜΑΤΟΔΟΤΗΣΗ ΕΡΕΥΝΗΤΙΚΩΝ ΠΡΟΓΡΑΜΜΑΤΩΝ
GRANTS/FUNDING
ΚΡΗΠΙΣ,ΓΓΕΤ
MRC
HEFCE CLS award, Higher Education Funding Council for England
E-rare Consortium: Epinostics ‘Autoimmune Liver Diseases: Epitope peptide
mapping’ EU FP7 grant
The Guy's & St Thomas' Charity Prize
Herakleitos GSRT, Hellenic Ministry of Development
Liver Immunodiagnostics 2736 –KCH Renal & Liver
EASL Post-doc Level Research Fellowship (2 fellowships)
EASL Entry Level Research Fellowship (3 fellowships)
EASL Visiting Research Fellowship (2 fellowship)
Leventis Foundation Fellowship
Liver Immunodiagnostics MJL9103 –Gene and Cell Based Therapy
King’s Charitable Trust
Alex Mowat Research Trust
Executive Academic Committee –ILS
Children’s Liver Disease Foundation
Fast Track UCL Research Committee
T.F.C Frost Charitable Trust
Multiple Sclerosis Society of Great Britain and Northern Ireland
Chronic Fatigue Syndrome Research Foundation
Action Research Foundation
PBC Foundation
Psoriasis Foundation
Συνδιοργανωτής-Μέλος Οργανωτικής Επιτροπής Συνεδρίων
1) Συνδιοργανωτής του 1ου Israel-Greek International Meeting of
Rheumatology and Autoimmunity, Haifa, Israel, 15 October 2015
2) Μέλος, Organising Committee of the 12th Dresden Symposium on
Autoantibodies, Dresden, September 2015
3) Μέλος, Scientific Committee, EASL Monothematic Conference: Primary
Biliary Cirrhosis (PBC), Milan, Italy, 23 & 24 May 2014
4) Μέλος, International Advisory Committee of the 9t Autoimmunity
Congress 2014, Nice, France, March 2014
5) Μέλος, Organising Committee of the 11th Dresden Symposium,
Dresden, Germany, September 2013
6) Μέλος, International Scientific Committee of the 8th Senftenberg
Innovation Forum 2014 on Multiparametric Analysis: Autoimmunity
Diagnostics, Senftenberg, Germany
7) Μέλος τηε Οργανωτικής Επιτροπής του 4ου (Σεπτέμβριος 2014) και του
5ου (Σεπτέμβριος 2015) Συνεδρίου Ρευματολογίας και Αυτοάνοσων
Παθήσεων Κεντρικής Ελλάδας, Λάρισα
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
14
ΟΜΙΛΙΕΣ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ ΓΙΑ ΤΟ ΑΚΑΔΗΜΑΙΚΟ ΕΤΟΣ 2013-2015 11th Dresden Symposium on Autoantibodies 1-4 September 2013 Τίτλος Ομιλίας: Possible role of infections in the pathogenesis of autoimmune liver diseases (είμαι επίσης μέλος της Scientific Organizing Committee) 11th Dresden Symposium on Autoantibodies 1-4 September 2013 Τίτλος Ομιλίας: GP2– The link between innate and acquired immune system in the intestine 25th Congress of the International Academy of Pathology - Arab Division. Amman, Jordan 7-9 November 2013 Τίτλος Ομιλίας: Autoimmunity in Inflammatory Bowel Diseases 25th Congress of the International Academy of Pathology - Arab Division. Amman, Jordan 7-9 November 2013 ̎Τίτλος Ομιλίας: Autoimmune Pancreatitis
25th Congress of the International Academy of Pathology - Arab Division. Amman, Jordan 7-9 November 2013 Τίτλος Ομιλίας: Risk Factors of Autoimmunity
8th Autoimmunity Congress, Nice, France 26-30 March, 2014 Τίτλος Ομιλίας: Infectome (είμαι επίσης μέλος της Scientific Organizing Committee) 8th Senftenberg Innovation Forum on Multiparametric Analysis: Autoimmunity Diagnostics, Senftenberg, Germany 7 & 8 May 2014
Τίτλος Ομιλίας: The desire to study the autoinfectome: a multiparametric approach EASL Monothematic Conference: Primary Biliary Cirrhosis (PBC) 23 & 24 May 2014 Τίτλος Ομιλίας: The role of B cells in Primary Biliary Cirrhosis 47th Annual meeting ESPGHAN 9-12 June 2014 Τίτλος Ομιλίας: Immunopathogenetic links between IBD and autoimmune liver disease
12th Dresden Symposium on Autoantibodies 23-26 September 2015 Τίτλος Ομιλίας: Autoantibodies in liver autoimmunity: diagnostic clinical and prognostic significance 12th Dresden Symposium on Autoantibodies
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
15
23-25 September 2015 Τίτλος Ομιλίας: Autoinfectome: a tool to study the link between infection and autoimmunity 1st Israel-Greek meeting of Rheumatology and Autoimmune diseases 15 October 2015 Τίτλος Ομιλίας: the role of molecular mimicry in autoimmune liver diseases
ΔΗΜΟΣΙΕΥΣΕΙΣ ΕΡΓΑΣΙΩΝ
Σύνολο: 181
157 αναφέρονται στο Pubmed
http://www.ncbi.nlm.nih.gov/pubmed/?term=Bogdanos
Δημοσιεύσεις όπως αναφέρονται στο Pubmed
1: Sakkas LI, Bogdanos DP. Systemic sclerosis: new evidence re-enforces the role of B cells. Autoimmun Rev. 2015 Oct 20. pii: S1568-9972(15)00217-7. doi: 10.1016/j.autrev.2015.10.005. [Epub ahead of print] PubMed PMID: 26497107. Review article 2: Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari C, Bogdanos DP, Sakkas LI. B regulatory cells are decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol. 2015 Sep 28. doi: 10.1002/art.39437. [Epub ahead of print] PubMed PMID: 26414243. Original article 3: Pavlidis P, Komorowski L, Teegen B, Liaskos C, Koutsoumpas AL, Smyk DS,
Perricone C, Mytilinaiou MG, Stocker W, Forbes A, Bogdanos DP. Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies. Clin Chem Lab Med. 2015 Jul 18. doi: 10.1515/cclm-2015-0376. [Epub ahead of print] PubMed PMID: 26351932. Original article 4: Villalta D, Mytilinaiou MG, Elsner M, Hentschel C, Cuccato J, Somma V, Schierack P, Roggenbuck D, Bogdanos DP. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases. Clin Chim Acta. 2015 Oct 23;450:1-5. doi: 10.1016/j.cca.2015.07.021. Epub 2015 Jul 26. PubMed PMID: 26220739. Original article 5: Norman GL, Gatselis NK, Shums Z, Liaskos C, Bogdanos DP, Koukoulis GK, Dalekos GN. Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. World J Hepatol. 2015 Jul 18;7(14):1875-83. doi: 10.4254/wjh.v7.i14.1875. Original
6: Efe C, Bogdanos DP. Reply: To PMID 25002309. Dig Dis Sci. 2015 Apr;60(4):1107-8. PubMed PMID: 26086058. Letter 7: Scholz J, Grossmann K, Knütter I, Hiemann R, Sowa M, Röber N, Rödiger S, Schierack P, Reinhold D, Bogdanos DP, Meroni PL, Radice A, Conrad K, Roggenbuck D. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing. Clin Chem Lab Med. 2015 May 15. pii: /j/cclm.ahead-of-print/cclm-2015-0083/cclm-2015-0083.xml. doi: 10.1515/cclm-2015-0083. [Epub ahead of print] PubMed PMID: 26020561. Original 8: Sowa M, Grossmann K, Knütter I, Hiemann R, Röber N, Anderer U, Csernok E,
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
16
Bogdanos DP, Borghi MO, Meroni PL, Schierack P, Reinhold D, Conrad K, Roggenbuck D. Correction: Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA. PLoS One. 2015 May 13;10(5):e0127933. doi:
10.1371/journal.pone.0127933. eCollection 2015. PubMed PMID: 25970179; PubMed Central PMCID: PMC4430479. Not listed in the total number of papers 9: Bogdanos DP, Smyk DS, Rigopoulou EI, Sakkas LI, Shoenfeld Y. Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity. Lupus. 2015 Apr;24(4-5):364-73. doi: 10.1177/0961203314559088. PubMed PMID: 25801879. 10: Gkretsi V, Bogdanos DP. Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis. Exp Cell Res. 2015 Jun 10;334(2):219-27. doi: 10.1016/j.yexcr.2015.03.002. Epub 2015 Mar 12. PubMed PMID: 25773778. 11: Gkretsi V, Bogdanos DP. Elimination of Ras Suppressor-1 from hepatocellular carcinoma cells hinders their in vitro metastatic properties. Anticancer Res. 2015 Mar;35(3):1509-12. PubMed PMID: 25750304.
12: Sakkas LI, Simopoulou T, Katsiari C, Bogdanos DP, Chikanza IC. Early systemic sclerosis-opportunities for treatment. Clin Rheumatol. 2015 Aug;34(8):1327-31. doi: 10.1007/s10067-015-2902-5. Epub 2015 Feb 26. PubMed PMID: 25711876. 13: Roggenbuck D, Röber N, Bogdanos DP, Goihl A, Reinhold D, Conrad K, Laass MW. Autoreactivity to isoforms of glycoprotein 2 in inflammatory bowel disease. Clin Chim Acta. 2015 Mar 10;442:82-3. doi: 10.1016/j.cca.2015.01.018. Epub 2015 Jan 24. PubMed PMID: 25625482. 14: Koutsoumpas AL, Smyk DS, Bogdanos DP. E. coli Induced Experimental Model of Primary Biliary Cirrhosis: At Last. Int J Hepatol. 2014;2014:848373. doi: 10.1155/2014/848373. Epub 2014 Dec 16. Review. PubMed PMID: 25580301; PubMed Central PMCID: PMC4280654. 15: Liaskos C, Spyrou V, Athanasiou LV, Orfanidou T, Mavropoulos A, Rigopoulou EI, Amiridis GS, Shoenfeld Y, Billinis C, Bogdanos DP. Crohn's disease-specific
anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis. Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):384-90. doi: 10.1016/j.clinre.2014.12.001. Epub 2015 Jan 6. PubMed PMID: 25575461. 16: Cantarini L, Rigante D, Vitale A, Napodano S, Sakkas LI, Bogdanos DP, Shoenfeld Y. Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future. Immunol Res. 2015 Mar;61(3):326-37. doi: 10.1007/s12026-014-8615-z. PubMed PMID: 25550086. 17: Pavlidis P, Shums Z, Koutsoumpas AL, Milo J, Papp M, Umemura T, Lakatos PL, Smyk DS, Bogdanos DP, Forbes A, Norman GL. Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA. Clin Chim Acta. 2015 Feb 20;441:176-81. doi: 10.1016/j.cca.2014.12.010. Epub 2014 Dec 12. PubMed PMID: 25512163. 18: Roggenbuck D, Vermeire S, Hoffman I, Reinhold D, Schierack P, Goihl A, von
Arnim U, De Hertogh G, Polymeros D, Bogdanos DP, Bossuyt X. Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease. Clin Chem Lab Med. 2015 Aug 1;53(9):1349-57. doi: 10.1515/cclm-2014-0238. PubMed PMID: 25411995. 19: Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos DP, Milkiewicz P. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis. Liver Int. 2015 Jun;35(6):1764-71. doi: 10.1111/liv.12730. Epub 2014 Dec 4. PubMed PMID: 25388280. 20: Sowa M, Grossmann K, Knütter I, Hiemann R, Röber N, Anderer U, Csernok E,
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
17
Bogdanos DP, Borghi MO, Meroni PL, Schierack P, Reinhold D, Conrad K, Roggenbuck D. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA. PLoS One. 2014 Sep 16;9(9):e107743. doi:
10.1371/journal.pone.0107743. eCollection 2014 21: Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun Rev. 2014 Nov;13(11):1114-20. doi: 10.1016/j.autrev.2014.08.012. Epub 2014 Aug 23. Review. PubMed PMID: 25182207. 22: Polymeros D, Tsiamoulos ZP, Koutsoumpas AL, Smyk DS, Mytilinaiou MG, Triantafyllou K, Bogdanos DP, Ladas SD. Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease. BMC Med. 2014 Aug 28;12:139. doi: 10.1186/s12916-014-0139-9. PubMed PMID: 25168804; PubMed Central PMCID: PMC4171545. 23: Zachou K, Gampeta S, Gatselis NK, Oikonomou K, Goulis J, Manoussakis MN, Renaudineau Y, Bogdanos DP, Dalekos GN. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with
autoimmune hepatitis. Liver Int. 2015 Feb;35(2):660-72. doi: 10.1111/liv.12658. Epub 2014 Aug 27. PubMed PMID: 25113420. 24: Efe C, Kav T, Aydin C, Cengiz M, Imga NN, Purnak T, Smyk DS, Torgutalp M, Turhan T, Ozenirler S, Ozaslan E, Bogdanos DP. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci. 2014 Dec;59(12):3035-42. doi: 10.1007/s10620-014-3267-3. Epub 2014 Jul 8. PubMed PMID: 25002309. 25: Maslyanskiy A, Lazareva N, Olinek P, Schierack P, Hentschel C, Cuccato J, Bogdanos DP, Lapin SV, Roggenbuck D. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis. J Immunol Res. 2014;2014:516593. doi: 10.1155/2014/516593. Epub 2014 May 4. PubMed PMID: 24883333; PubMed Central PMCID: PMC4027001.
26: Milkiewicz M, Kopycińska J, Kempińska-Podhorodecka A, Haas T, Bogdanos DP, Elias E, Milkiewicz P. Ursodeoxycholic acid influences the expression of p27kip1 but not FoxO1 in patients with non-cirrhotic primary biliary cirrhosis. J Immunol Res. 2014;2014:921285. doi: 10.1155/2014/921285. Epub 2014 Feb 5. PubMed PMID: 24741631; PubMed Central PMCID: PMC3987973. 27: Kotarska K, Wunsch E, Kempińska-Podhorodecka A, Raszeja-Wyszomirska J, Bogdanos DP, Wójcicki M, Milkiewicz P. Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study. J Immunol Res. 2014;2014:738297. doi: 10.1155/2014/738297. Epub 2014 Mar 4. PubMed PMID: 24741621; PubMed Central PMCID: PMC3987938. 28: Mavropoulos A, Bogdanos DP, Liaskos C, Orfanidou T, Simopoulou T, Zafiriou E, Sakkas LI, Rigopoulou EI. Flow cytometric detection of p38 MAPK phosphorylation and intracellular cytokine expression in peripheral blood subpopulations from
patients with autoimmune rheumatic diseases. J Immunol Res. 2014;2014:671431. doi: 10.1155/2014/671431. Epub 2014 Feb 3. PubMed PMID: 24741615; PubMed Central PMCID: PMC3987974. 29: Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014 Jan 21;20(3):613-29. doi: 10.3748/wjg.v20.i3.613. Review. PubMed PMID: 24574735; PubMed Central PMCID: PMC3921471. 30: Rigopoulou EI, Bogdanos DP. Is primary biliary cirrhosis rare or common? The truth lies somewhere in between. Liver Int. 2014 Aug;34(7):e165-7. doi: 10.1111/liv.12488. PubMed PMID: 24517310.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
18
31: Bogdanos DP, Smyk D, Shoenfeld Y. The microbiome of the lung. Isr Med Assoc J. 2013 Dec;15(12):766-7. PubMed PMID: 24449982.
32: Roggenbuck D, Reinhold D, Schierack P, Bogdanos DP, Conrad K, Laass MW. Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges. Clin Chem Lab Med. 2014 Apr;52(4):483-94. doi: 10.1515/cclm-2013-0801. Review. PubMed PMID: 24231127. 33: Smyk DS, Mytilinaiou MG, Grammatikopoulos T, Knisely AS, Mieli-Vergani G, Bogdanos DP, Vergani D. Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis. Clin Dev Immunol. 2013;2013:642643. doi: 10.1155/2013/642643. Epub 2013 Sep 19. PubMed PMID: 24171034; PubMed Central PMCID: PMC3792542. 34: Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol. 2013;2013:569751. doi: 10.1155/2013/569751. Epub 2013 Sep 12. Review. PubMed PMID: 24151518; PubMed Central PMCID: PMC3787653.
35: Iacovakis C, Mamuris Z, Moutou KA, Touloudi A, Hammer AS, Valiakos G, Giannoulis T, Stamatis C, Spyrou V, Athanasiou LV, Kantere M, Asferg T, Giannakopoulos A, Salomonsen CM, Bogdanos DP, Birtsas P, Petrovska L, Hannant D, Billinis C. Polarisation of major histocompatibility complex II host genotype with pathogenesis of European Brown Hare syndrome virus. PLoS One. 2013 Sep 19;8(9):e74360. doi: 10.1371/journal.pone.0074360. eCollection 2013. PubMed PMID: 24069299; PubMed Central PMCID: PMC3778001. 36: Mavropoulos A, Orfanidou T, Liaskos C, Smyk DS, Spyrou V, Sakkas LI, Rigopoulou EI, Bogdanos DP. p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. Autoimmune Dis. 2013;2013:728529. doi: 10.1155/2013/728529. Epub 2013 Jul 10. PubMed PMID: 23936634; PubMed Central PMCID: PMC3722958. 37: Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis.
Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):572-85. doi: 10.1016/j.clinre.2013.04.005. Epub 2013 Jul 19. PubMed PMID: 23876351. 38: Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):535-45. doi: 10.1016/j.clinre.2013.05.016. Epub 2013 Jul 8. Review. PubMed PMID: 23845396. 39: Pavlidis P, Forbes A, Bogdanos DP. Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch. J Crohns Colitis. 2013 Dec;7(11):e602-3. doi: 10.1016/j.crohns.2013.06.010. Epub 2013 Jul 9. PubMed PMID: 23845232. 40: Mahler M, Bogdanos DP, Pavlidis P, Fritzler MJ, Csernok E, Damoiseaux J, Bentow C, Shums Z, Forbes A, Norman GL. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Clin Chim Acta. 2013 Sep 23;424:267-73. doi: 10.1016/j.cca.2013.06.005. Epub 2013 Jun 24. PubMed PMID:
23806819. 41: Somma V, Ababneh H, Ababneh A, Gatti S, Romagnoli V, Bendia E, Conrad K, Bogdanos DP, Roggenbuck D, Ciarrocchi G. The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease. Gastroenterol Res Pract. 2013;2013:683824. doi: 10.1155/2013/683824. Epub 2013 May 15. PubMed PMID: 23762038; PubMed Central PMCID: PMC3671301. 42: Roggenbuck D, Reinhold D, Werner L, Schierack P, Bogdanos DP, Conrad K. Glycoprotein 2 antibodies in Crohn's disease. Adv Clin Chem. 2013;60:187-208. Review. PubMed PMID: 23724745.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
19
43: Bogdanos DP, Gao B, Gershwin ME. Liver immunology. Compr Physiol. 2013 Apr;3(2):567-98. doi: 10.1002/cphy.c120011. Review. PubMed PMID: 23720323; PubMed Central PMCID: PMC4201126.
44: Liaskos C, Rigopoulou EI, Orfanidou T, Bogdanos DP, Papandreou CN. CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases. Clin Dev Immunol. 2013;2013:968041. doi: 10.1155/2013/968041. Epub 2013 Apr 22. Review. PubMed PMID: 23710207; PubMed Central PMCID: PMC3654630. 45: Raszeja-Wyszomirska J, Wunsch E, Kempinska-Podhorodecka A, Smyk DS, Bogdanos DP, Milkiewicz M, Milkiewicz P. TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis. Clin Dev Immunol. 2013;2013:510547. doi: 10.1155/2013/510547. Epub 2013 Apr 28. PubMed PMID: 23710202; PubMed Central PMCID: PMC3655458. 46: Liaskos C, Spyrou V, Roggenbuck D, Athanasiou LV, Orfanidou T, Mavropoulos A, Reinhold D, Rigopoulou EI, Amiridis GS, Billinis C, Bogdanos DP. Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: implications for the pathogenesis of the human disease.
Autoimmunity. 2013 Sep;46(6):388-94. doi: 10.3109/08916934.2013.786047. Epub 2013 May 2. PubMed PMID: 23638886. 47: Kundzer AV, Volkova MV, Bogdanos DP, Rödiger S, Schierack P, Generalov I, Nevinsky GA, Roggenbuck D. Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides. Immunol Res. 2013 Jul;56(2-3):457-64. doi: 10.1007/s12026-013-8424-9. PubMed PMID: 23592052. 48: Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Sakkas L, Pouria S, Shoenfeld Y. Tracing environmental markers of autoimmunity: introducing the infectome. Immunol Res. 2013 Jul;56(2-3):220-40. doi: 10.1007/s12026-013-8399-6. Review. PubMed PMID: 23592050. 49: Invernizzi P, Bossuyt X, Bogdanos DP. Serum autoantibodies: from identification to clinical relevance. Clin Dev Immunol. 2013;2013:382069. doi: 10.1155/2013/382069. Epub 2013 Mar 20. PubMed PMID: 23573110; PubMed Central
PMCID: PMC3615582. 50: Smyk D, Rigopoulou EI, Bizzaro N, Bogdanos DP. Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights. 2012 Jan 13;4(1):1-9. doi: 10.1007/s13317-011-0027-7. eCollection 2013 Apr. PubMed PMID: 26000137; PubMed Central PMCID: PMC4389085. 51: Roggenbuck D, Hiemann R, Bogdanos DP, Reinhold D, Conrad K. Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta. 2013 Jun 5;421:168-9. doi: 10.1016/j.cca.2013.03.019. Epub 2013 Mar 26. PubMed PMID: 23537734. 52: Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis. Clin Dev
Immunol. 2013;2013:572815. doi: 10.1155/2013/572815. Epub 2013 Jan 16. PubMed PMID: 23401700; PubMed Central PMCID: PMC3562650. 53: Roggenbuck D, Bogdanos DP, Conrad K. Loss of tolerance to one or two major targets in Crohn's disease or just cross-reactivity? J Crohns Colitis. 2013 Aug;7(7):e273-4. doi: 10.1016/j.crohns.2012.12.013. Epub 2013 Jan 20. PubMed PMID: 23337370. 54: Probst C, Radzimski C, Blöcker IM, Teegen B, Bogdanos DP, Stöcker W, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
20
Clin Chim Acta. 2013 Mar 15;418:91-6. doi: 10.1016/j.cca.2013.01.003. Epub 2013 Jan 16. PubMed PMID: 23333419.
55: Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, Rödiger S, Anderer U, Conrad K, Bogdanos DP, Reinhold D, Roggenbuck D. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol. 2012;2012:284740. doi: 10.1155/2012/284740. Epub 2012 Dec 19. Review. PubMed PMID: 23316252; PubMed Central PMCID: PMC3536031. 56: Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S, Shoenfeld Y. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev. 2013 May;12(7):726-40. doi: 10.1016/j.autrev.2012.12.005. Epub 2012 Dec 22. Review. PubMed PMID: 23266520. 57: Smyk DS, Bogdanos DP, Pares A, Liaskos C, Billinis C, Burroughs AK, Rigopoulou EI. Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature. Tuberc Res Treat. 2012;2012:218183. doi: 10.1155/2012/218183. Epub 2012 Oct 30. PubMed PMID: 23213506; PubMed Central PMCID: PMC3504403.
58: Mavropoulos A, Orfanidou T, Liaskos C, Smyk DS, Billinis C, Blank M, Rigopoulou EI, Bogdanos DP. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmun Rev. 2013 Mar;12(5):580-90. doi: 10.1016/j.autrev.2012.10.019. Epub 2012 Nov 30. Review. PubMed PMID: 23207287. 59: Ehser J, Holdener M, Christen S, Bayer M, Pfeilschifter JM, Hintermann E, Bogdanos DP, Christen U. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. J Autoimmun. 2013 May;42:39-49. doi: 10.1016/j.jaut.2012.11.001. Epub 2012 Nov 28. PubMed PMID: 23200317. 60: Smyk DS, Rigopoulou EI, Bogdanos DP. Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New? Curr Infect Dis Rep. 2013 Feb;15(1):14-24. doi: 10.1007/s11908-012-0304-2. PubMed PMID: 23188623.
61: Smyk DS, Bogdanos DP, Mytilinaiou MG, Burroughs AK, Rigopoulou EI. Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence? Arthritis. 2012;2012:391567. doi: 10.1155/2012/391567. Epub 2012 Oct 24. PubMed PMID: 23150824; PubMed Central PMCID: PMC3488395. 62: Kempinska-Podhorodecka A, Shums Z, Wasilewicz M, Wunsch E, Milkiewicz M, Bogdanos DP, Norman GL, Milkiewicz P. TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis. Clin Dev Immunol. 2012;2012:487521. doi: 10.1155/2012/487521. Epub 2012 Oct 22. PubMed PMID: 23125866; PubMed Central PMCID: PMC3485529. 63: Pavlidis P, Romanidou O, Roggenbuck D, Mytilinaiou MG, Al-Sulttan F, Liaskos C, Smyk DS, Koutsoumpas AL, Rigopoulou EI, Conrad K, Forbes A, Bogdanos DP. Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease. Clin Dev Immunol.
2012;2012:640835. doi: 10.1155/2012/640835. Epub 2012 Oct 17. PubMed PMID: 23118780; PubMed Central PMCID: PMC3483735. 64: Bogdanos DP, Gershwin ME. What is new in primary biliary cirrhosis? Dig Dis. 2012;30 Suppl 1:20-31. doi: 10.1159/000341118. Epub 2012 Oct 11. Review. PubMed PMID: 23075865. 65: Roggenbuck D, Humbel RL, Reinhold D, Bogdanos DP, Conrad K, Laass MW. Glycoprotein 2 antibodies in inflammatory bowel disease: no association with disease phenotype? J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):e5. doi: 10.1097/MPG.0b013e318275fa77. PubMed PMID: 23059646.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
21
66: Smyk D, Rigopoulou EI, Zen Y, Abeles RD, Billinis C, Pares A, Bogdanos DP. Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? World J Gastroenterol. 2012 Sep 21;18(35):4855-65. Review. PubMed PMID: 23002357;
PubMed Central PMCID: PMC3447267. 67: Smyk DS, Rigopoulou EI, Pares A, Mytilinaiou MG, Invernizzi P, Bogdanos DP. Familial primary biliary cirrhosis: like mother, like daughter? Acta Gastroenterol Belg. 2012 Jun;75(2):203-9. Review. PubMed PMID: 22870783. 68: Bogdanos DP, Roggenbuck D, Reinhold D, Wex T, Pavlidis P, von Arnim U, Malfertheiner P, Forbes A, Conrad K, Laass MW. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. BMC Gastroenterol. 2012 Aug 6;12:102. PubMed PMID: 22866900; PubMed Central PMCID: PMC3449192. 69: Smyk DS, Rigopoulou EI, Koutsoumpas AL, Kriese S, Burroughs AK, Bogdanos DP. Autoantibodies in autoimmune pancreatitis. Int J Rheumatol. 2012;2012:940831. doi: 10.1155/2012/940831. Epub 2012 Jul 12. PubMed PMID: 22844291; PubMed Central PMCID: PMC3403403.
70: Invernizzi P, Alessio MG, Smyk DS, Lleo A, Sonzogni A, Fabris L, Candusso M, Bogdanos DP, Iorio R, Torre G. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol. 2012 Jul 20;12:92. doi: 10.1186/1471-230X-12-92. Review. PubMed PMID: 22816667; PubMed Central PMCID: PMC3464927. 71: Smyk DS, Rigopoulou EI, Pares A, Billinis C, Burroughs AK, Muratori L, Invernizzi P, Bogdanos DP. Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol. 2012;2012:610504. doi: 10.1155/2012/610504. Epub 2012 May 30. Review. PubMed PMID: 22693524; PubMed Central PMCID: PMC3369468. 72: Rigopoulou EI, Smyk DS, Matthews CE, Billinis C, Burroughs AK, Lenzi M, Bogdanos DP. Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol. 2012;2012:987471. doi: 10.1155/2012/987471. Epub 2012 May 28. PubMed PMID:
22693505; PubMed Central PMCID: PMC3368154. 73: Rigopoulou EI, Roggenbuck D, Smyk DS, Liaskos C, Mytilinaiou MG, Feist E, Conrad K, Bogdanos DP. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012 Dec;12(2):260-9. doi: 10.1016/j.autrev.2012.04.005. Epub 2012 May 1. Review. PubMed PMID: 22571878. 74: Mytilinaiou MG, Meyer W, Scheper T, Rigopoulou EI, Probst C, Koutsoumpas AL, Abeles D, Burroughs AK, Komorowski L, Vergani D, Bogdanos DP. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta. 2012 Aug 16;413(15-16):1211-6. doi: 10.1016/j.cca.2012.03.020. Epub 2012 Apr 3. PubMed PMID: 22503841. 75: Duarte-Rey C, Bogdanos DP, Yang CY, Roberts K, Leung PS, Anaya JM, Worman HJ, Gershwin ME. Primary biliary cirrhosis and the nuclear pore complex. Autoimmun
Rev. 2012 Oct;11(12):898-902. doi: 10.1016/j.autrev.2012.03.005. Epub 2012 Apr 1. Review. PubMed PMID: 22487189; PubMed Central PMCID: PMC3396748. 76: Smyk DS, Mytilinaiou MG, Milkiewicz P, Rigopoulou EI, Invernizzi P, Bogdanos DP. Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights. 2011 Sep 7;3(1):1-9. doi: 10.1007/s13317-011-0023-y. eCollection 2012 Apr. Review. PubMed PMID: 26000122; PubMed Central PMCID: PMC4389021. 77: Rigamonti C, Bogdanos DP, Mytilinaiou MG, Smyk DS, Rigopoulou EI, Burroughs AK. Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol. 2011;2011:976427. doi: 10.1155/2011/976427.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
22
Epub 2011 Dec 6. PubMed PMID: 22187566; PubMed Central PMCID: PMC3236477. 78: Duarte-Rey C, Bogdanos DP, Leung PS, Anaya JM, Gershwin ME. IgM predominance
in autoimmune disease: genetics and gender. Autoimmun Rev. 2012 May;11(6-7):A404-12. doi: 10.1016/j.autrev.2011.12.001. Epub 2011 Dec 8. Review. PubMed PMID: 22178509. 79: Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, Gershwin ME. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2012 May;38(2-3):J156-69. doi: 10.1016/j.jaut.2011.11.003. Epub 2011 Dec 15. Review. PubMed PMID: 22177232. 80: Smyk DS, Rigopoulou EI, Muratori L, Burroughs AK, Bogdanos DP. Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. Ann Hepatol. 2012 Jan-Feb;11(1):7-14. Review. PubMed PMID: 22166556. 81: Zen Y, Bogdanos DP, Kawa S. Type 1 autoimmune pancreatitis. Orphanet J Rare Dis. 2011 Dec 7;6:82. doi: 10.1186/1750-1172-6-82. Review. PubMed PMID: 22151922; PubMed Central PMCID: PMC3261813.
82: Smyk DS, Rigopoulou EI, Lleo A, Abeles RD, Mavropoulos A, Billinis C, Invernizzi P, Bogdanos DP. Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing. 2011 Dec 2;8(1):12. doi: 10.1186/1742-4933-8-12. PubMed PMID: 22136162; PubMed Central PMCID: PMC3238302. 83: Mavropoulos A, Smyk D, Rigopoulou EI, Bogdanos DP. Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases. Methods Mol Biol. 2012;806:275-85. doi: 10.1007/978-1-61779-367-7_19. PubMed PMID: 22057459. 84: Bogdanos DP, Rigopoulou EI, Smyk DS, Roggenbuck D, Reinhold D, Forbes A, Laass MW, Conrad K. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev. 2011 Dec;11(2):143-8. doi: 10.1016/j.autrev.2011.09.004. Epub 2011 Sep 29. Review. PubMed PMID: 21983481.
85: Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Clin Res Hepatol Gastroenterol. 2012 Apr;36(2):110-21. doi: 10.1016/j.clinre.2011.07.013. Epub 2011 Sep 8. Review. PubMed PMID: 21907008. 86: Smyk D, Cholongitas E, Kriese S, Rigopoulou EI, Bogdanos DP. Primary biliary cirrhosis: family stories. Autoimmune Dis. 2011;2011:189585. doi: 10.4061/2011/189585. Epub 2011 May 5. PubMed PMID: 21687641; PubMed Central PMCID: PMC3112499. 87: Smyk D, Grammatikopoulos T, Daponte A, Rigopoulou EI, Bogdanos DP. Fetomaternal alloimmunity as a cause of liver disease. Auto Immun Highlights. 2011 Mar 23;2(1):21-8. doi: 10.1007/s13317-011-0019-7. eCollection 2011 May. Review. PubMed PMID: 26000116; PubMed Central PMCID: PMC4389071.
88: Koutsoumpas A, Polymeros D, Tsiamoulos Z, Smyk D, Karamanolis G, Triantafyllou K, Rigopoulou EI, Forbes A, Vergani D, Bogdanos DP, Ladas SD. Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis. 2011 Apr;5(2):101-9. doi: 10.1016/j.crohns.2010.10.009. Epub 2010 Dec 3. PubMed PMID: 21453878. 89: Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP. Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol. 2012 Apr;42(2):199-212. doi: 10.1007/s12016-011-8259-x. Review. PubMed PMID: 21337133. 90: Pavlidis P, Forbes A, Bogdanos DP. Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK. Clin Chim Acta. 2011 May
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
23
12;412(11-12):1163-4. doi: 10.1016/j.cca.2011.02.005. Epub 2011 Feb 15. PubMed PMID: 21329686.
91: Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers. 2010;29(6):337-44. doi: 10.3233/DMA-2010-0744. Review. PubMed PMID: 21297253; PubMed Central PMCID: PMC3835285. 92: Bogdanos DP, Baum H, Vergani D, Burroughs AK. The role of E. coli infection
in the pathogenesis of primary biliary cirrhosis. Dis Markers. 2010;29(6):301-11.
doi: 10.3233/DMA-2010-0745. Review. PubMed PMID: 21297249; PubMed Central PMCID:
PMC3835537.
93: Roggenbuck D, Reinhold D, Wex T, Goihl A, von Arnim U, Malfertheiner P, Büttner T, Porstmann T, Porstmann S, Liedvogel B, Bogdanos DP, Laass MW, Conrad K. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta. 2011 Apr 11;412(9-10):718-24. doi: 10.1016/j.cca.2010.12.029. Epub 2010 Dec 31. PubMed PMID: 21195704.
94: Bogdanos DP, Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011 Mar 18;412(7-8):502-12. doi: 10.1016/j.cca.2010.12.019. Epub 2010 Dec 23. Review. PubMed PMID: 21185272. 95: Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote EJ, Hirschfield GM, Tan EM, Miyachi K, Bignotto M, Battezzati PM, Lleo A, Leung PS, Podda M, Gershwin ME, Invernizzi P. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010 Dec;35(4):436-42. doi: 10.1016/j.jaut.2010.09.005. Epub 2010 Oct 6. PubMed PMID: 20932720. 96: Koutsoumpas A, Mytilinaiou M, Polymeros D, Dalekos GN, Bogdanos DP. Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J
Gastroenterol Hepatol. 2009 Oct;21(10):1220. doi: 10.1097/MEG.0b013e32831a4807. PubMed PMID: 19749508. 97: Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis. 2009 Aug;29(3):241-53. doi: 10.1055/s-0029-1233533. Epub 2009 Aug 12. Review. PubMed PMID: 19675997. 98: Mytilinaiou MG, Bogdanos DP. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis. Dig Liver Dis. 2009 Dec;41(12):916; author reply 916-7. doi: 10.1016/j.dld.2009.05.005. Epub 2009 Jul 14. PubMed PMID: 19604733. 99: Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G. Autoimmune hepatitis. Semin Immunopathol. 2009 Sep;31(3):421-35. doi: 10.1007/s00281-009-0170-7. Epub 2009 Jun 17. Review. PubMed PMID: 19533129.
100: Dähnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos DP, Vergani D, Stöcker W, Komorowski L. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009 May;55(5):978-85. doi: 10.1373/clinchem.2008.118299. Epub 2009 Mar 5. PubMed PMID: 19264849. 101: Bogdanos DP, Dalekos GN. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem. 2008;15(22):2285-92. Review. PubMed PMID: 18781950. 102: Bogdanos DP, Pusl T, Rust C, Vergani D, Beuers U. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
24
Sep;49(3):466-73. doi: 10.1016/j.jhep.2008.05.022. Epub 2008 Jun 25. PubMed PMID: 18644655.
103: Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008 Jun 7;14(21):3374-87. Review. PubMed PMID: 18528935; PubMed Central PMCID: PMC2716592. 104: Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009 Feb;36(1):30-9. doi: 10.1007/s12016-008-8087-9. Review. PubMed PMID: 18498061. 105: Granito A, Stanzani M, Muratori L, Bogdanos DP, Muratori P, Pappas G, Quarneti C, Lenzi M, Vergani D, Bianchi FB. LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation. Am J Gastroenterol. 2008 May;103(5):1313-4. doi: 10.1111/j.1572-0241.2007.01782_7.x. PubMed PMID: 18477361. 106: Dalekos GN, Bogdanos DP, Neuberger J. Celiac disease-related autoantibodies
in end-stage autoimmune liver diseases: what is the message? Liver Int. 2008 Apr;28(4):426-8. doi: 10.1111/j.1478-3231.2008.01708.x. PubMed PMID: 18339068. 107: Bernal W, Meda F, Ma Y, Bogdanos DP, Vergani D. Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology. 2008 Mar;47(3):1096-7; author reply 1097. doi: 10.1002/hep.22179. PubMed PMID: 18306217. 108: Rigopoulou EI, Davies ET, Bogdanos DP, Liaskos C, Mytilinaiou M, Koukoulis GK, Dalekos GN, Vergani D. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int. 2007 Nov;27(9):1226-31. PubMed PMID: 17919234. 109: Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology. 2007
Aug;46(2):472-84. PubMed PMID: 17559153. 110: Bogdanos DP, Liaskos C, Pares A, Norman G, Rigopoulou EI, Caballeria L, Dalekos GN, Rodes J, Vergani D. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology. 2007 Jun;45(6):1583; author reply 1583-4. PubMed PMID: 17538935. 111: Rigopoulou EI, Bogdanos DP, Liaskos C, Koutsoumpas A, Baum H, Vergani D, Dalekos GN. Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta. 2007 May 1;380(1-2):118-21. Epub 2007 Feb 1. PubMed PMID: 17321509. 112: Liaskos C, Bogdanos DP, Rigopoulou EI, Dalekos GN. Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol. 2007 Mar;22(3):454-5. PubMed PMID:
17295788. 113: Rigopoulou EI, Dalekos G, Bogdanos DP. How common are connective tissue disorders in patients with autoimmune hepatitis? Semin Arthritis Rheum. 2007 Apr;36(5):332; author reply 333. Epub 2007 Feb 5. PubMed PMID: 17276497. 114: Liaskos C, Bogdanos DP, Davies ET, Dalekos GN. Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol. 2007 Jan;60(1):107-8. PubMed PMID: 17213359; PubMed Central PMCID: PMC1860582. 115: Bogdanos DP, Rigopoulou EI. Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
25
Diabetes Res Clin Pract. 2007 Jul;77(1):155-6. Epub 2006 Nov 21. PubMed PMID: 17118481.
116: Mullighan CG, Bogdanos DP, Vergani D, Bardy PG. Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease. Bone Marrow Transplant. 2006 Nov;38(10):703-5. Epub 2006 Sep 25. PubMed PMID: 17001344. 117: Bogdanos DP, Koutsoumpas A, Baum H, Vergani D. Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis. Dig Liver Dis. 2006 Oct;38(10):781-2; author reply 782-3. Epub 2006 Jul 25. PubMed PMID: 16870516. 118: Bogdanos DP, Vergani D. Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int. 2006 Aug;26(6):633-5. Review. PubMed PMID: 16842317. 119: Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology. 2006 Jul;131(1):85-96. PubMed PMID: 16831593.
120: Bogdanos DP, Rigopoulou EI. Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine. 2006 Sep 11;24(37-39):6173-4. Epub 2006 Jun 9. PubMed PMID: 16806599. 121: Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta. 2006 Nov;373(1-2):183-4; author reply 185. Epub 2006 Apr 7. PubMed PMID: 16714006. 122: Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006 Mar;130(3):868-82. PubMed PMID: 16530525. 123: Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D. A study of
molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol. 2005 Sep;12(3):217-24. PubMed PMID: 16295528; PubMed Central PMCID: PMC2275415. 124: Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology. 2005 Aug;42(2):458-65. PubMed PMID: 16025495. 125: Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, Mieli-Vergani G, Vergani D. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005 Aug;25(1):63-71. PubMed PMID: 16005184. 126: Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani
G, Bianchi FB, Vergani D. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005 Jun;3(6):595-603. PubMed PMID: 15952102. 127: Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005 Apr;54(4):528-32. PubMed PMID: 15753539; PubMed Central PMCID: PMC1774444. 128: Bogdanos DP, Mieli-Vergani G, Vergani D. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin Infect Dis. 2005 Feb 15;40(4):508-10. Epub 2005 Jan 21. PubMed PMID: 15712071.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
26
129: Ma Y, Meregalli M, Hodges S, Davies N, Bogdanos DP, Fargion S, Fiorelli G, Vergani D. Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease. Int J Immunopathol Pharmacol. 2005 Jan-Mar;18(1):173-82.
PubMed PMID: 15698522. 130: Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y, Mieli-Vergani G, Vergani D. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis. 2004 Nov 19;1(1):4. PubMed PMID: 15679947; PubMed Central PMCID: PMC546408. 131: Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol. 2004 Oct;39(10):981-7. PubMed PMID: 15513338. 132: Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004 Jul;41(1):31-7. PubMed PMID: 15246204.
133: Bogdanos DP, Mieli-Vergani G, Vergani D. Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis. 2004 May 15;38(10):1505; author reply 1505-6. PubMed PMID: 15156495. 134: Bogdanos DP, Vergani D, Muratori P, Muratori L, Bianchi FB. Specificity of anti-sp100 antibody for primary biliary cirrhosis. Scand J Gastroenterol. 2004 Apr;39(4):405-6; author reply 407. PubMed PMID: 15125479. 135: Bogdanos DP, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, Burroughs AK, Rodes J, Vergani D. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun. 2004 Jun;22(4):353-62. PubMed PMID: 15120760.
136: Bogdanos DP, Pares A, Rodés J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol. 2004 Apr;99(4):763-4; author reply 765. PubMed PMID: 15089915. 137: Bogdanos DP, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli- Vergani G, Bianchi FB, Vergani D. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol. 2004 Jan-Apr;17(1):83-92. PubMed PMID: 15000871. 138: Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D. Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem. 2004 Mar;50(3):682-3; author reply 683-4. PubMed PMID: 14981048. 139: Vergani D, Bogdanos DP, Baum H. Unusual suspects in primary biliary cirrhosis. Hepatology. 2004 Jan;39(1):38-41. Review. PubMed PMID: 14752820.
140: Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003 Nov;35(11):801-5. PubMed PMID: 14674671. 141: Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004 Jan;40(1):31-9. PubMed PMID: 14672611. 142: Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003 Nov;7(4):759-77, vi. Review. PubMed PMID: 14594130.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
27
143: Bogdanos DP, McFarlane IG. Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol. 2003 Nov;39(5):860-3. Review.
PubMed PMID: 14568272. 144: Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos DP, Vegnente A, Mieli-Vergani G, Vergani D. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003 Sep;133(3):404-13. PubMed PMID: 12930368; PubMed Central PMCID: PMC1808793. 145: Hannam S, Bogdanos DP, Davies ET, Hussain MJ, Portmann BC, Mieli-Vergani G, Vergani D. Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity. 2002 Dec;35(8):545-50. PubMed PMID: 12765481. 146: Vergani D, Bogdanos DP. Positive markers in AMA-negative PBC. Am J Gastroenterol. 2003 Feb;98(2):241-3. PubMed PMID: 12591035.
147: Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003 Feb 1;170(3):1481-9. PubMed PMID: 12538711. 148: Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002 Aug;6(3):727-37. Review. PubMed PMID: 12362577. 149: Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB, Mieli-Vergani G, Vergani D. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol. 2002 Jul 1;169(1):277-85. PubMed PMID: 12077255. 150: Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, Vergani D.
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med. 2001 Jul;1(3):379-89. Review. PubMed PMID: 11899084. 151: Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Dürr R, Mieli-Vergani G, Vergani D. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002 Mar;35(3):658-64. PubMed PMID: 11870381. 152: Bogdanos DP, Baum H, Sharma UC, Grasso A, Ma Y, Burroughs AK, Vergani D. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol. 2002 Jan;36(1):14-21. PubMed PMID: 11804659. 153: Bogdanos DP, Mieli-Vergani G, Vergani D. Liver-kidney microsomal antibody-positive autoimmune hepatitis in the United States. Am J Gastroenterol. 2001 Dec;96(12):3447-8. PubMed PMID: 11774973.
154: Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001 Aug;21(4):225-32. Review. PubMed PMID: 11454184. 155: Baum H, Bogdanos DP, Vergani D. Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol. 2001 May;34(5):785-7. PubMed PMID: 11434633. 156: Bogdanos DP, Mieli-Vergani G, Vergani D. Virus, liver and autoimmunity. Dig Liver Dis. 2000 Jun-Jul;32(5):440-6. PubMed PMID: 11030191.
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
28
157: Bogdanos DP, Muratori L, Bianchi FB, Vergani D. Hepatitis C virus and autoimmunity. Hepatology. 2000 Jun;31(6):1380. PubMed PMID: 10866525.
Additional Publications not deposited in Pubmed 158: Mavropoulos A, Koutsoumpas A, Bogdanos DP, Sakkas LI. The role of p38 MAP in autoimmune diseases. Inter Trends Immun 2014; 3(2) 2015, 1-17 160: Smyk DS, Bogdanos DP, Rigopoulou EI. Risk factors for autoimmune hepatitis. From genes and pregnancy to vaccination and pollutants. Immuno-Gastroenterology 2013, 2(1); 29-37 161: Roggenbuck D, Reinhold D, Wex T, von Arnim U, Malfertheiner P, Sturn A, Werner L, Bogdanos DP, Laass MW, Conrad K. The Authors’ reply. Gut 2012 61: 164-165; doi: 10.1136/gut.2010.237214 162: Smyk DS, Rigopouloy EI, Zen Y, Koutsoumpas A, Baum H, Bogdanos DP. Infectious
triggers of primary biliary cirrhosis: do we know enough? Curr Trends Immunol 2010 11: 35-49
163: Bogdanos DP, Christen U. Autoimmune hepatitis: an update on current animal models.The Open Pathology Journal 2008;2:39-45 164: Bogdanos DP, Vergani D, Mieli-Vergani G. Overlap syndromes from pediatrics to adulthood. J Gastroenterol Hepatol 2004;19:S284-6
ΚΕΦΑΛΑΙΑ ΣΕ ΒΙΒΛΙΑ
165: Bogdanos DP, Smyk DS, Sakkas LI, Shoenfeld Y. Chapter 9: Infection and
Autoimmunity, 2nd edition, Y Shoenfeld, N Agmon-Levin, N Rose, 01/2015:: pp149-
162; Academic Press, 2015 166: Bogdanos DP, Leung PSC, Gershwin ME. Chapter 87: Liver and biliary tract. In
Mucosal Immunology 4th Edition, Vol 2 Editors Jiri Mestecky, Warren Strober, Michael W. Russell, Brian L. Kelsall, Hide Cheroutre, Bart Lambrecht, pp 1695-1717, Academic Press, 2015
167: Smyk DS, Sakkas LI, Shoenfeld Y, Bogdanos DP. Hepatitis B Vaccination and Autoimmunity in Vaccines and autoimmunity, pp.147-162 Editors: Yehuda Shoenfeld, Nancy Agmon-Levin, Lucija Tomljenovic Publisher: Wiley-Blackwell, Oxford 2014
168: Antico A, Tampoia M, Bogdanos D, Tozzolli R. Gastric autoantibodies. pp 359-364. In Autoantibodies 3rd Edition. Editors: Y Shoenfeld, PL Meroni, ME Gershwin. Elsevier, Oxford, 2014
169: Conrad K, Bogdanos D, Roggenbuck D. Antipancreatic antibodies.Chapter 51, pp.433-440. In Autoantibodies 3rd Edition. Editors: Y Shoenfeld, PL Meroni, ME Gershwin. Elsevier, Oxford, 2014
170: Bogdanos DP, Rigamonti C, Milkiewicz P, Rigopoulou EI, Burroughs AK. Emerging
issues in the immunopathogenesis, diagnosis and clinical management of primary biliary cirrhosis associated with systemic sclerosis. In ‘Systemic Sclerosis’ Editor: T. Radstake; Publishers: Intech; ISBN 978-953-307-869-4, 2011
171: Bogdanos DP, Conrad K, Smyk DS, Rigopoulou EI, Forbes A. Novel autoantibody markers in autoimmune gastrointestinal and liver diseases. pp288-301 Editors K. Conrad, Pabst Science Publishers, Lengerich, Germany, 2011 From Prediction to Prevention of Autoimmune Diseases. by K. Conrad, E. K. L. Chan, M. J. Fritzler, R.L. Humbel, P. L. Meroni, Y. Shoenfeld (Eds.)
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
29
172. L. Komorowski, D.P Bogdanos, C. Probst, C. Dähnrich, A. Rosemann, W. Schlumberger, W. Stöcker: Detection of primary biliary cirrhosis-associated anti-mitochondrial antibodies using an improved test system: Anti-M2/BPO ELISA. From
Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies Chapter 6.2 Gastrointestinal and Liver Diseases (in press) K. Conrad, E.K.L. Chan, M.J. Fritzler, U. Sack, Y. Shoenfeld, A.S. Wiik (Eds.)
173. W. Meyer, T. Scheper, N. Janssen, L. Komorowski, C. Probst, W. Schlumberger, D.P Bogdanos, W. Stöcker: A comprehensive line immunoassay for the detection of autoantibodies in primary biliary cirrhosis (PBC) From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies Chapter 6.2 Gastrointestinal and Liver Diseases K. Conrad, E.K.L. Chan, M.J. Fritzler, U. Sack, Y. Shoenfeld, A.S. Wiik (Eds.) Pabst Science Publishers, Lengerich, Germany
174. Ma Y, Longhi MS, Bogdanos DP, Mieli-Vergani G, Vergani D. Autoreactive T cells: any evidence in autoimmune liver disease? In “Autoimmune liver Diseases”. Falk Symposium 142, Kluwer Academic Publishers, Dordrecht, pages 49-58, 2004
175. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. In “Primary biliary cirrhosis”. Gitlin N, Heathcote EJ, Eds. Saunders, Philadelphia, USA. Pages 759-77, 2003
176. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. (2002) Role of molecular
mimicry in viral and autoimmune Liver Disease. In “Autoimmune diseases in pediatric gastroenterology ". Branski D, Hadziselimovic F, Harms K, Lentze M, Eds. Kluwer Academic Publishers, Dordrecht. Pages 9-12, 2002
177. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. In “Autoimmune hepatitis ". Gitlin N, Czaja A, Eds. Saunders, Philadelphia, USA. Pages 439-50, 2002
ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΠΕΡΙΟΔΙΚΑ 178 ΣΑΚΚΑΣ ΛΙ, ΜΑΥΡΟΠΟΥΛΟΣ Α, ΜΠΟΓΔΑΝΟΣ ΔΠ, Meditterranean J Rheumatolog-
Ελληνική Ρευματολογία, Mediterr J Rheumatol 2015; 26(1): 64-67 179. ΡΗΓΟΠΟΥΛΟΥ ΕΙ, ΜΠΟΓΔΑΝΟΣ ΔΠ.Νεότερα δεδομένα στην επιδημιολογία,
παθογένεια και θεραπεία της πρωτοπαθούς χολικής κίρρωσης.Ελληνική Ιατρική 2001;67 (sup1):93-100
179. ΛΑΠΠΑΣ Α, ΜΠΟΓΔΑΝΟΣ Δ, ΚΟΝΣΤΑΝΤΙΝΟΥ Γ, ΜΠΟΚΟΛΑΣ Γ, ΙΩΑΝΝΙΔΗΣ Κ, ΜΠΟΥΡΑ Π, ΚΟΥΝΤΟΥΡΑΣ Ι. Η αξία της δοκιμασίας ουρεάσης (CLO) σιάλου-οδοντικής πλάκας στην αντιμετώπιση ασθενών με πεπτικό έλκος και Helicobacter pylori λοίμωξη. Αρχεία Ελληνικής Ιατρικής 1997;14:330
ΜΟΝΟΓΡΑΦΙΕΣ
180. Bogdanos DP. Autoimmune Hepatitis: Confirmation of the diagnosis – Interprenting the Serology. pp.67-92 ‘Autoimmune hepatitis – a guide for practising physicians’ Editors: J Heathcote & G Hirschfield. Humana Press, 2011 181. Bogdanos Dimitrios-Petrou, Molecular mimicry in primary biliary cirrhosis and other hepatic and extra-hepatic diseases: PhD Thesis, Faculty of medicine, University of London, May 2005, pages 1-256 Από το ερευνητικό αντικείμενο της διατριβής μου προέκυψαν 12 διεθνείς δημοσιεύσεις (6 original articles)
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
30
Άλλα στοιχεία δημοσιεύσεων
Όταν αιτήθηκα τη θέση του Επίκουρου Καθηγητή Παθολογίας (Ιούλιος 2008), είχα 55 άρθρα στο PubMed. Το Σεπτέμβριο του 2011, που ανέλαβα καθήκοντα είχα 72. Όταν αιτήθηκα τη μονιμοποίησή μου στη βαθμίδα του Επικ. Καθηγητή είχα 126 άρθρα στην ηλεκτρονική βιβλιοθήκη PubMed. Μέχρι σήμερα έχω δημοσιεύσει 157 άρθρα στο Pubmed.
Citations Perish or Publish Citations: 5013 Google Scholar Citations: 4928 Scopus Citations: 4008 h-index: 39 (Publish or Perish); 39 (Google Scholar); 37 (Scopus)
Περιοδικά με δείκτη απήχησης (Impact factor) >6 & αριθμός δημοσιεύσεων σε αυτά
1. Gastroenterology (2 articles) 2. Gut (2 articles) 3. Hepatology (7 articles) 4. J of Hepatology (6 articles) 5. American J Gastroenterology (4 articles) 6. Clinical Infectious Diseases (2 articles) 7. J Autoimmunity (5 articles) 8. Arthritis & Rheumatology (1 article) 9. Autoimmunity Reviews (8 articles) 10. Clinical Gastroenterology Hepatology (1 article) 11. J Crohn’s Colitis (2 articles)
IF: 16.7 IF: 14.7 IF: 11.1 IF: 11.3 IF: 10.8 IF: 8.9 IF: 8.4 IF: 7.8 IF: 7.9 IF: 7.9 IF: 6.2
IF* of 2014
Συνολικός αριθμός δημοσιεύσεων με δείκτη απήχησης IF>6: 40 Median Journal’s IF δημοσιεύσεων με δείκτη απήχησης IF>6: 8.4
Google Scholar Λίστα Δημοσιεύσεων και Αναφορές ανά δημοσίευση
Τίτλος Αναφορές Χρόνος
Impairment of CD4+ CD25+ regulatory T-cells in autoimmune liver disease MS Longhi, Y Ma, DP Bogdanos, P Cheeseman, G Mieli-Vergani, ... Journal of hepatology 41 (1), 31-37
264 2004
Autoimmune hepatitis D Vergani, MS Longhi, DP Bogdanos, Y Ma, G Mieli-Vergani Seminars in immunopathology 31 (3), 421-435
203 2009
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease Y Ma, M Okamoto, MG Thomas, DP Bogdanos, AR Lopes, B Portmann, ... Hepatology 35 (3), 658-664
193 2002
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
31
Cytochrome P4502D6193–212: a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease N Kerkar, K Choudhuri, Y Ma, A Mahmoud, DP Bogdanos, L Muratori, ... The Journal of Immunology 170 (3), 1481-1489
168 2003
Autoimmune liver serology: current diagnostic and clinical challenges DP Bogdanos, P Invernizzi, IR Mackay, D Vergani World journal of gastroenterology: WJG 14 (21), 3374
165 2008
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis MS Longhi, Y Ma, RR Mitry, DP Bogdanos, M Heneghan, P Cheeseman, ... Journal of autoimmunity 25 (1), 63-71
149 2005
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences DP Bogdanos, K Choudhuri, D Vergani Liver 21 (4), 225-232
143 2001
Pathogenesis of autoimmune hepatitis D Vergani, K Choudhuri, DP Bogdanos, G Mieli-Vergani Clinics in liver disease 6 (3), 727-737
131 2002
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2 Y Ma, DP Bogdanos, MJ Hussain, J Underhill, S Bansal, MS Longhi, ... Gastroenterology 130 (3), 868-882
124 2006
Twin studies in autoimmune disease: genetics, gender and environment DP Bogdanos, DS Smyk, EI Rigopoulou, MG Mytilinaiou, MA Heneghan, ... Journal of autoimmunity 38 (2), J156-J169
123 2012
Antimitochondrial and other autoantibodies DP Bogdanos, H Baum, D Vergani Clinics in Liver Disease 7 (4), 759-777
100 2003
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection GV Gregorio, K Choudhuri, Y Ma, P Pensati, R Iorio, P Grant, J Garson, ... Clinical & Experimental Immunology 133 (3), 404-413
99 2003
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis EI Rigopoulou, ET Davies, A Pares, K Zachou, C Liaskos, DP Bogdanos, ... Gut 54 (4), 528-532
97 2005
Autoantibodies and their antigens in autoimmune hepatitis. DP Bogdanos, G Mieli-Vergani, D Vergani Seminars in liver disease 29 (3), 241-253
94 2009
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
32
Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2 MS Longhi, MJ Hussain, DP Bogdanos, A Quaglia, G Mieli‐Vergani, Y Ma, ... Hepatology 46 (2), 472-484
91 2007
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis DP Bogdanos, H Baum, A Grasso, M Okamoto, P Butler, Y Ma, ... Journal of hepatology 40 (1), 31-39
89 2004
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus-infected patients is associated with the possession of HLA B51 DP Bogdanos, M Lenzi, M Okamoto, EI Rigopoulou, P Muratori, Y Ma, ... International journal of immunopathology and pharmacology 17 (1), 83-92
76 2004
Primary biliary cirrhosis is characterized by IgG3 antibodies cross‐reactive with the major mitochondrial autoepitope and its Lactobacillus mimic DP Bogdanos, H Baum, M Okamoto, P Montalto, UC Sharma, ... Hepatology 42 (2), 458-465
74 2005
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis H Liu, GL Norman, Z Shums, HJ Worman, EL Krawitt, N Bizzaro, ... Journal of autoimmunity 35 (4), 436-442
73 2010
Disease-specific autoantibodies in primary biliary cirrhosis DP Bogdanos, L Komorowski Clinica Chimica Acta 412 (7), 502-512
69 2011
Virus, liver and autoimmunity DP Bogdanos, G Mieli-Vergani, D Vergani Digestive and Liver Disease 32 (5), 440-446, 2000
67 2000
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis DP Bogdanos, H Baum, UC Sharma, A Grasso, Y Ma, AK Burroughs, ... Journal of Hepatology 36 (1), 14-21, 2002
64 2002
New ELISA for Detecting Primary Biliary Cirrhosis–Specific Antimitochondrial Antibodies C Dähnrich, A Pares, L Caballeria, A Rosemann, W Schlumberger, ... Clinical Chemistry 55 (5), 978-985, 2009
61 2009
Bacteria and primary biliary cirrhosis DP Bogdanos, D Vergani Clinical reviews in allergy & immunology 36 (1), 30-39, 2009
60 2009
Susceptibility to thyroid disorders in hepatitis C L Muratori, DP Bogdanos, P Muratori, M Lenzi, A Granito, Y Ma, ... Clinical Gastroenterology and Hepatology 3 (6), 595-603, 2005
57 2005
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
33
Positive markers in AMA-negative PBC D Vergani, DP Bogdanos The American journal of gastroenterology 98 (2), 241-243, 2003
56 2003
Pediatric autoimmune liver diseases the molecular basis of humoral and cellular immunity LI Wen, Y Ma, DP Bogdanos, F Wong, G Mieli-Vergani, D Vergani Current Molecular Medicine 1 (3), 379-389, 2001
56 2001
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule Y Ma, MG Thomas, M Okamoto, DP Bogdanos, S Nagl, N Kerkar, ... The Journal of Immunology 169 (1), 277-285, 2002
55 2002
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis EI Rigopoulou, ET Davies, DP Bogdanos, C Liaskos, M Mytilinaiou, ... Liver International 27 (9), 1226-1231, 2007
52 2007
Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection DP Bogdanos, H Baum, P Butler, EI Rigopoulou, ET Davies, Y Ma, ... Digestive and Liver Disease 35 (11), 801-805, 2003
51 2003
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn’s disease? D Polymeros, DP Bogdanos, R Day, D Arioli, D Vergani, A Forbes Gastroenterology 131 (1), 85-96, 2006
50 2006
Infectome: a platform to trace infectious triggers of autoimmunity DP Bogdanos, DS Smyk, P Invernizzi, EI Rigopoulou, M Blank, S Pouria, ... Autoimmunity reviews 12 (7), 726-740, 2013
49 2013
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis DP Bogdanos, A Pares, H Baum, L Caballeria, EI Rigopoulou, Y Ma, ... Journal of autoimmunity 22 (4), 353-362, 2004
49 2004
A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics DP Bogdanos, H Smith, Y Ma, H Baum, G Mieli-Vergani, D Vergani Journal of Immunology Research 12 (3), 217-224, 2005
48 2005
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity DP Bogdanos, H Baum, F Gunsar, D Arioli, D Polymeros, Y Ma, ... Scandinavian journal of gastroenterology 39 (10), 981-987, 2004
48 2004
Autoimmunity and environment: am I at risk? D Smyk, EI Rigopoulou, H Baum, AK Burroughs, D Vergani, ... Clinical reviews in allergy & immunology 42 (2), 199-212, 2012
46 2012
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
34
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease D Roggenbuck, D Reinhold, T Wex, A Goihl, U von Arnim, P Malfertheiner, ... Clinica chimica acta 412 (9), 718-724, 2011
41 2011
Anti‐gp210 antibody mirrors disease severity in primary biliary cirrhosis DP Bogdanos, C Liaskos, A Pares, G Norman, EI Rigopoulou, ... Hepatology 45 (6), 1583-1583, 2007
40 2007
Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis D Bogdanos, T Pusl, C Rust, D Vergani, U Beuers Journal of hepatology 49 (3), 466-473, 2008
39 2008
Unusual suspects in primary biliary cirrhosis D Vergani, DP Bogdanos, H Baum Hepatology 39 (1), 38-41, 2004
39 2004
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies DP Bogdanos, EI Rigopoulou, DS Smyk, D Roggenbuck, D Reinhold, ... Autoimmunity reviews 11 (2), 143-148, 2011
38 2011
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found EI Rigopoulou, D Roggenbuck, DS Smyk, C Liaskos, MG Mytilinaiou, ... Autoimmunity reviews 12 (2), 260-269, 2012
37 2012
Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s DP Bogdanos, GN Dalekos Current medicinal chemistry 15 (22), 2285-2292, 2008
36 2008
New platform technology for comprehensive serological diagnostics of autoimmune diseases A Willitzki, R Hiemann, V Peters, U Sack, P Schierack, S Rödiger, ... Clinical and Developmental Immunology 2012, 2012
35 2012
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis EI Rigopoulou, DP Bogdanos, C Liaskos, A Koutsoumpas, H Baum, ... Clinica Chimica Acta 380 (1), 118-121, 2007
35 2007
Type 1 autoimmune pancreatitis Y Zen, DP Bogdanos, S Kawa Orphanet J Rare Dis 6 (1), 82, 2011
33 2011
Primary biliary cirrhosis: family stories D Smyk, E Cholongitas, S Kriese, EI Rigopoulou, DP Bogdanos Autoimmune diseases 2011, 2011
33 2011
Origin of cross‐reactive autoimmunity in primary biliary cirrhosis DP BOGDANOS, D VERGANI Liver International 26 (6), 633-635, 2006
33 2006
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
35
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis DP Bogdanos, H Baum, D Vergani, AK Burroughs Disease markers 29 (6), 301-311, 2010
31 2010
Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? DP Bogdanos, G Mieli-Vergani, D Vergani Clinical Infectious Diseases 40 (4), 508-510, 2005
28 2005
Antibodies to soluble liver antigen and α-enolase in patients with autoimmune hepatitis DP Bogdanos, D Gilbert, I Bianchi, S Leoni, RR Mitry, Y Ma, ... Journal of autoimmune diseases 1 (1), 4, 2004
28 2004
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease DP Bogdanos, D Roggenbuck, D Reinhold, T Wex, P Pavlidis, ... BMC gastroenterology 12 (1), 102, 2012
26 2012
Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside DS Smyk, DP Bogdanos, S Kriese, C Billinis, AK Burroughs, ... Clinics and research in hepatology and gastroenterology 36 (2), 110-121, 2012
25 2012
Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope H Baum, DP Bogdanos, D Vergani Journal of hepatology 34 (5), 785-787, 2001
25 2001
IgM predominance in autoimmune disease: genetics and gender C Duarte-Rey, DP Bogdanos, PSC Leung, JM Anaya, ME Gershwin Autoimmunity reviews 11 (6), A404-A412, 2012
24 2012
Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis DS Smyk, EI Rigopoulou, L Muratori, AK Burroughs, DP Bogdanos Ann Hepatol 11 (1), 7-14, 2012
24 2012
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain DP Bogdanos, A Pares, J Rodés, D Vergani The American journal of gastroenterology 99 (4), 763-764, 2004
24 2004
PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York D Smyk, MG Mytilinaiou, EI Rigopoulou, DP Bogdanos Disease markers 29 (6), 337-344, 2010
23 2010
Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn’s disease P Pavlidis, O Romanidou, D Roggenbuck, MG Mytilinaiou, F Al-Sulttan, ... Clinical and Developmental Immunology 2012, 2012
22 2012
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
36
Autoantibodies in autoimmune pancreatitis DS Smyk, EI Rigopoulou, AL Koutsoumpas, S Kriese, AK Burroughs, ... International journal of rheumatology 2012, 2012
21 2012
Sex differences associated with primary biliary cirrhosis DS Smyk, EI Rigopoulou, A Pares, C Billinis, AK Burroughs, L Muratori, ... Clinical and developmental immunology 2012, 2012
21 2012
Epstein-barr virus as a trigger of autoimmune liver diseases EI Rigopoulou, DS Smyk, CE Matthews, C Billinis, AK Burroughs, M Lenzi, ... Advances in virology 2012, 2012
20 2012
Immunopathogenesis of primary biliary cirrhosis: an old wives’ tale DS Smyk, EI Rigopoulou, A Lleo, RD Abeles, A Mavropoulos, C Billinis, ... Immunity & Ageing 8 (1), 12, 2011
20 2011
Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies A Koutsoumpas, M Mytilinaiou, D Polymeros, GN Dalekos, DP Bogdanos European journal of gastroenterology & hepatology 21 (10), 1220, 2009
20 2009
Disease‐specific autoantibodies in patients with acute liver failure: The King's College London Experience W Bernal, F Meda, Y Ma, DP Bogdanos, D Vergani Hepatology 47 (3), 1096-1097, 2008
20 2008
Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity DP Bogdanos, IG McFarlane Journal of hepatology 39 (5), 860-863, 2003
20 2003
Vitamin D in autoimmune liver disease DS Smyk, T Orfanidou, P Invernizzi, DP Bogdanos, M Lenzi Clinics and research in hepatology and gastroenterology 37 (5), 535-545, 2013
19 2013
Primary biliary cirrhosis and the nuclear pore complex C Duarte-Rey, D Bogdanos, CY Yang, K Roberts, PSC Leung, JM Anaya, ... Autoimmunity reviews 11 (12), 898-902, 2012
19 2012
Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis J Ehser, M Holdener, S Christen, M Bayer, JM Pfeilschifter, E Hintermann, ... Journal of autoimmunity 42, 39-49, 2013
18 2013
Glycoprotein 2 antibodies in Crohn’s disease D Roggenbuck, D Reinhold, L Werner, P Schierack, DP Bogdanos, ... Adv Clin Chem 60, 187-208, 2013
18 2013
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
37
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis MG Mytilinaiou, W Meyer, T Scheper, EI Rigopoulou, C Probst, ... Clinica Chimica Acta 413 (15), 1211-1216, 2012
18 2012
Specificity of anti-sp100 antibody for primary biliary cirrhosis. DP Bogdanos, D Vergani, P Muratori, L Muratori, FB Bianchi Scandinavian journal of gastroenterology 39 (4), 405-6; author reply 407, 2004
18 2004
p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris A Mavropoulos, T Orfanidou, C Liaskos, DS Smyk, C Billinis, M Blank, ... Autoimmunity reviews 12 (5), 580-590, 2013
16 2013
Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK P Pavlidis, A Forbes, DP Bogdanos Clinica Chimica Acta 412 (11), 1163-1164, 2011
16 2011
Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis C Liaskos, DP Bogdanos, ET Davies, GN Dalekos Journal of clinical pathology 60 (1), 107-108, 2007
16 2007
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen DP Bogdanos, C Liaskos, EI Rigopoulou, GN Dalekos Clinica Chimica Acta 373 (1), 183-184, 2006
16 2006
Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis DP Bogdanos, A Koutsoumpas, H Baum, D Vergani Digestive and Liver Disease 38 (10), 781-782, 2006
16 2006
Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes DP Bogdanos, EI Rigopoulou Diabetes research and clinical practice 77 (1), 155-156, 2007
15 2007
Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease Y Ma, M Meregalli, S Hodges, N Davies, DP Bogdanos, S Fargion, ... International journal of immunopathology and pharmacology 18 (1), 173-182, 2005
15 2005
Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis JA Underhill, Y Ma, DP Bogdanos, P Cheeseman, G Mieli-Vergani, ... Journal of Hepatology 36, 156, 2002
15 2002
Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies S Hannam, DP Bogdanos, ET Davies, MJ Hussain, BC Portmann, ... Autoimmunity 35 (8), 545-550, 2002
15 2002
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
38
Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? C Liaskos, DP Bogdanos, EI Rigopoulou, GN Dalekos Journal of gastroenterology and hepatology 22 (3), 454-455, 2007
14 2007
Crohn’s disease specific pancreatic antibodies: clinical and pathophysiological challenges D Roggenbuck, D Reinhold, P Schierack, DP Bogdanos, K Conrad, ... Clinical Chemistry and Laboratory Medicine 52 (4), 483-494, 2014
13 2014
Liver immunology DP Bogdanos, B Gao, ME Gershwin Comprehensive Physiology, 2013
13 2013
Standardization of automated interpretation of immunofluorescence tests D Roggenbuck, R Hiemann, D Bogdanos, D Reinhold, K Conrad Clinica Chimica Acta, 168-169, 2013
13 2013
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges C Rigamonti, DP Bogdanos, MG Mytilinaiou, DS Smyk, EI Rigopoulou, ... International journal of rheumatology 2011, 2011
13 2011
Authors' response: antibodies to GP2, the major zymogen granule membrane glycoprotein, are specific for Crohn's disease and may reflect treatment response D Roggenbuck, D Reinhold, T Wex, U von Arnim, P Malfertheiner, ... Gut, gut. 2010.237214, 2011
13 2011
Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis DP Bogdanos, I Bianchi, Y Ma, RR Mitry, G Mieli-Vergani, D Vergani Clinical chemistry 50 (3), 682-684, 2004
13 2004
Tracing environmental markers of autoimmunity: introducing the infectome DP Bogdanos, DS Smyk, P Invernizzi, EI Rigopoulou, M Blank, L Sakkas, ... Immunologic research 56 (2-3), 220-240, 2013
12 2013
Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis MG Mytilinaiou, DP Bogdanos Digestive and Liver Disease 41 (12), 916, 2009
12 2009
Hepatitis C virus and autoimmunity. DP Bogdanos, L Muratori, FB Bianchi, D Vergani Hepatology (Baltimore, Md.) 31 (6), 1380-1380, 2000
12 2000
What is new in primary biliary cirrhosis? DP Bogdanos, ME Gershwin Digestive Diseases 30 (Suppl. 1), 20-31, 2012
11 2012
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
39
Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease CG Mullighan, DP Bogdanos, D Vergani, PG Bardy Bone marrow transplantation 38 (10), 703-705, 2006
11 2006
The novel Crohn's disease marker anti-GP2 antibody is associated with ileocolonic location of disease V Somma, H Ababneh, A Ababneh, S Gatti, V Romagnoli, E Bendia, ... Gastroenterology research and practice 2013, 2013
10 2013
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature P Invernizzi, MG Alessio, DS Smyk, A Lleo, A Sonzogni, L Fabris, ... BMC gastroenterology 12 (1), 92, 2012
10 2012
Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease A Koutsoumpas, D Polymeros, Z Tsiamoulos, D Smyk, G Karamanolis, ... Journal of Crohn's and Colitis 5 (2), 101-109, 2011
10 2011
Self-mimicking autoimmune domains of hepatitis C virus core antigen DP Bogdanos, EI Rigopoulou Vaccine 24 (37), 6173-6174, 2006
10 2006
Non—Organ-Specific Autoantibodies in Children with Chronic Hepatitis C Virus Infection DP Bogdanos, G Mieli-Vergani, D Vergani Clinical infectious diseases 38 (10), 1505-1505, 2004
10 2004
Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis R Liberal, CR Grant, L Sakkas, N Bizzaro, DP Bogdanos Clinics and research in hepatology and gastroenterology 37 (6), 572-585, 2013
9 2013
PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease M Mahler, DP Bogdanos, P Pavlidis, MJ Fritzler, E Csernok, ... Clinica Chimica Acta 424, 267-273, 2013
9 2013
The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis A Mavropoulos, EI Rigopoulou, C Liaskos, DP Bogdanos, LI Sakkas Clinical and Developmental Immunology 2013, 2013
9 2013
Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against “rings and rods”-associated inosine-5′-monophosphate dehydrogenase 2 in viral hepatitis C C Probst, C Radzimski, IM Blöcker, B Teegen, DP Bogdanos, W Stöcker, ... Clinica Chimica Acta 418, 91-96, 2013
9 2013
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
40
Loss of tolerance to one or two major targets in Crohn's disease or just cross-reactivity? D Roggenbuck, D Bogdanos, K Conrad Journal of Crohn's and Colitis 7 (7), e273-e274, 2013
8 2013
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? D Smyk, EI Rigopoulou, Y Zen, RD Abeles, C Billinis, A Pares, ... World journal of gastroenterology: WJG 18 (35), 4855, 2012
8 2012
Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. DP Bogdanos, A Grasso, M Okamoto, P Montalto, P Butler, R Williams, ... Hepatology 32 (4), 300A-300A, 2000
8 2000
p38 MAPK signaling in pemphigus: implications for skin autoimmunity A Mavropoulos, T Orfanidou, C Liaskos, DS Smyk, V Spyrou, LI Sakkas, ... Autoimmune diseases 2013, 2013
7 2013
Potential roles for infectious agents in the pathophysiology of primary biliary cirrhosis: what’s new? DS Smyk, EI Rigopoulou, DP Bogdanos Current infectious disease reports 15 (1), 14-24, 2013
7 2013
LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation A Granito, M Stanzani, L Muratori, DP Bogdanos, P Muratori, G Pappas, ... The American journal of gastroenterology 103 (5), 1313-1314, 2008
7 2008
Liver-kidney microsomal antibody-positive autoimmune hepatitis in the United States DP Bogdanos, G Mieli-Vergani, D Vergani The American journal of gastroenterology 96 (12), 3447-3448, 2001
7 2001
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22 DS Smyk, MG Mytilinaiou, P Milkiewicz, EI Rigopoulou, P Invernizzi, ... Autoimmunity Highlights 3 (1), 1-9, 2012
6 2012
Anti-SLA antibody is a marker of severity of liver damage in patients with autoimmune liver disease Y Ma, DP Bogdanos, R Willams, G Mieli-Vergani, D Vergani Journal of Hepatology 34, 212, 2001
6 2001
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases C Liaskos, EI Rigopoulou, T Orfanidou, DP Bogdanos, CN Papandreou Clinical and Developmental Immunology 2013, 2013
5 2013
Familial primary biliary cirrhosis: like mother, like daughter? DS Smyk, EI Rigopoulou, A Pares, MG Mytilinaiou, P Invernizzi, ... Acta gastro-enterologica Belgica 75 (2), 203-209, 2012
5 2012
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
41
Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases A Mavropoulos, D Smyk, EI Rigopoulou, DP Bogdanos Human Cell Culture Protocols, 275-285, 2012
5 2012
1107 PHOSHORYLATION OF P38 MAPK IS DETECTABLE IN NKT CELLS OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN WHOM IT MIRRORS DISEASE ACTIVITY A Mavropoulos, E Spyrou, EI Rigopoulou, D Vergani, GN Dalekos, ... Journal of hepatology 52, S428, 2010
5 2010
Celiac disease‐related autoantibodies in end‐stage autoimmune liver diseases: what is the message? GN Dalekos, DP Bogdanos, J Neuberger Liver International 28 (4), 426-428, 2008
5 2008
Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis D Smyk, EI Rigopoulou, N Bizzaro, DP Bogdanos Autoimmunity Highlights 4 (1), 1-9, 2013
4 2013
Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence? DS Smyk, DP Bogdanos, MG Mytilinaiou, AK Burroughs, EI Rigopoulou Arthritis 2012, 2012
4 2012
TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis A Kempinska-Podhorodecka, Z Shums, M Wasilewicz, E Wunsch, ... Clinical and Developmental Immunology 2012, 2012
4 2012
Pancreatic GP2-specific autoantibodies are markers of Crohn's disease P Pavlidis, MG Mytilinaiou, D Roggenbuck, K Conrad, A Forbes, ... Gut 60 (Suppl 1), A212-A213, 2011
4 2011
Glutathionine S-transferase theta 1 (Gstt1) mismatch does not account for post liver transplant de novo autoimmune hepatitis T Grammatikopoulos, MG Mytilinaiou, DP Bogdanos, RJ Thompson, ... Hepatology 50 (4), 635A-636A, 2009
4 2009
Generation of liver/kidney microsomal-1 antibody in HCV infection: The role of molecular mimicry DP Bogdanos, M Lenzi, M Okamoto, Y Ma, L Muratori, R Williams, ... Journal of Hepatology 32, 92, 2000
4 2000
Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides AV Kundzer, MV Volkova, DP Bogdanos, S Rödiger, P Schierack, ... Immunologic research 56 (2-3), 457-464, 2013
3 2013
TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis J Raszeja-Wyszomirska, E Wunsch, A Kempinska-Podhorodecka, ... Clinical and Developmental Immunology 2013, 2013
3 2013
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
42
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature DS Smyk, DP Bogdanos, A Pares, C Liaskos, C Billinis, AK Burroughs, ... Tuberculosis research and treatment 2012, 2012
3 2012
Oral inverted ductal papilloma: Report of a case with immunohistochemical study A Epivatianos, D Antoniades, T Zaraboukas, AK Poulopoulos Open Pathology Journal 2, 1-5, 2008
3 2008
17 Functional impairment of CD25+ CD4+ regulatory T cells characterizes autoimmune hepatitis type 2 Y Ma, MS Longhi, DP Bogdanos, G Mieli-Vergani, D Vergani Hepatology 38, 163, 2003
3 2003
Cross-reactivity between mycobacterium gordonae and PDC-E2, the major target of anti-mitochondrial antibody, is present in Spanish but not British patients with PBC DP Bogdanos, A Pares, UC Sharma, L Caballeria, Y Ma, AK Burroughs, ... Journal of Hepatology 34, 19, 2001
3 2001
Autoantibodies to soluble liver antigen/UGA suppressor tRNA-associated antigenic protein are specific to autoimmune liver disease. Y Ma, M Okamoto, MG Thomas, R Durr, DP Bogdanos, R Williams, ... Hepatology 32 (4), 310A-310A, 2000
3 2000
Ursodeoxycholic Acid Influences the Expression of but Not FoxO1 in Patients with Non-Cirrhotic Primary Biliary Cirrhosis M Milkiewicz, J Kopycińska, A Kempińska-Podhorodecka, T Haas, ... Journal of immunology research 2014, 2014
2 2014
Crohn’s disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: Implications for the pathogenesis of the human disease C Liaskos, V Spyrou, D Roggenbuck, LV Athanasiou, T Orfanidou, ... Autoimmunity 46 (6), 388-394, 2013
2 2013
Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis C Radzimski, C Probst, B Teegen, K Rentzsch, IM Blöcker, C Dähnrich, ... Clinical and Developmental Immunology 2013, 2013
2 2013
Anti-asialoglycoprotein receptor antibody measured by ELISA is a specific marker of liver autoimmunity and mirrors disease activity in patients with autoimmune hepatitis MG Mytilinaiou, D Roggenbuck, A Grammatikopoulos, E Davies, ... Hepatology 54, 919A-919A, 2011
2 2011
Fetomaternal alloimmunity as a cause of liver disease D Smyk, T Grammatikopoulos, A Daponte, EI Rigopoulou, DP Bogdanos Autoimmunity Highlights 2 (1), 21-28, 2011
2 2011
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
43
Infectious triggers of primary biliary cirrhosis: do we know enough? D Smyk, EI Rigopoulou, Z Yoh, A Koutsoumpas, H Baum, DP Bogdanos Current trends in immunology, Volume 11, 35-49, 2010
2 2010
How common are connective tissue disorders in patients with autoimmune hepatitis? EI Rigopoulou, G Dalekos, DP Bogdanos Seminars in arthritis and rheumatism 36 (5), 332, 2007
2 2007
626 In vitro immunosuppressive effect of vitamin D3 in primary biliary cirrhosis C Almerighi, DP Bogdanos, V Cholongitas, I Carey, E Meda, MJ Hussain, ... Journal of Hepatology 44, S232-S233, 2006
2 2006
AUTOIMMUNE LIVER DISEASE/SYSTEMIC LUPUS ERYTHEMATOSUS OVERLAP SYNDROME IN CHILDREN: PH2-10 M Samyn, D Bogdanos, Y Ma, B Portmann, D Vergani, G Mieli-Vergani Journal of Pediatric Gastroenterology and Nutrition 40 (5), 681, 2005
2 2005
Overlap syndromes from pediatrics to adulthood D BOGDANOS, D VERGANI, G MIELI‐VERGANI Journal of Gastroenterology and Hepatology 19 (s7), S284-S286, 2004
2 2004
Immunodominant HLA-A2 restricted CD8 T cell epitope in autoimmune hepatitis type 2. MS Longhi, Y Ma, DP Bogdanos, G Mieli-Vergani, D Vergani Hepatology 40 (4), 422A-422A, 2004
2 2004
P0295 virus-self crossreactivity inducing De Novo autoimmune hepatitis eight-years after liver transplantation DP Bogdanos, Y Ma, N Hadzic, B Portmann, G Mieli-Vergani, D Vergani Journal of Pediatric Gastroenterology and Nutrition 39, S169, 2004
2 2004
Virus/self double reactivity characterises the humoral immune responsein autoimmune hepatitis-2 DP Bogdanos, M Okamoto, Y Ma, R Williams, G Mieli-Vergani, D Vergani Journal of Hepatology 32, 45, 2000
2 2000
Double reactivity to Ecoli/pyruvate dehydrogenase complex-E2characterises primary biliary cirrhosis DP Bogdanos, A Grasso, M Okamoto, P Butler, R Williams, H Baum, ... Journal of Hepatology 32, 39, 2000
2 2000
Cross-reactive immunity explains thyroid autoimmunity in Liver/Kidney Microsomal-1 positive hepatitis C virus infected patients DP Bogdanos, M Lenzi, Y Ma, P Aluigi, F Lari, L Muratori, R Williams, ... Hepatology 30 (4), 460A-460A, 1999
2 1999
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch P Pavlidis, A Forbes, DP Bogdanos Journal of Crohn's and Colitis 7 (11), e602-e603, 2013
1 2013
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
44
Polarisation of Major Histocompatibility Complex ii host genotype with pathogenesis of European brown hare syndrome virus C Iacovakis, Z Mamuris, KA Moutou, A Touloudi, AS Hammer, G Valiakos, ...
1 2013
Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis DS Smyk, MG Mytilinaiou, T Grammatikopoulos, AS Knisely, ... Clinical and Developmental Immunology 2013, 2013
1 2013
Serum autoantibodies: from identification to clinical relevance DP Bogdanos Clinical and Developmental Immunology 2013, 2013
1 2013
Risk Factors for Autoimmune Hepatitis: From Genes and Pregnancy to Vaccinations and Pollutants DS Smyk, DP Bogdanos, EI Rigopoulou
1 2013
Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases reply D Roggenbuck, D Reinhold, T Wex, U von Arnim, P Malfertheiner, ... Gut 61 (1), 164-165, 2012
1 2012
Innate Immunity in Gastrointestinal Disorders: Basic and Therapeutic Concepts H Tilg, R Blumberg, S Enders, A Kaser, M Manns Digestive Diseases 30 (Suppl. 1), 1-1, 2012
1 2012
Emerging issues in the immunopathogenesis, diagnosis and clinical management of primary biliary cirrhosis associated with systemic sclerosis DP Bogdanos, AK Burroughs, C Rigamonti, D Smyk, EI Rigopoulou, ... INTECH Open Access Publisher, 2012
1 2012
Pr3-ANCA in Inflammatory Bowel Disease: A Useful Marker to Differentiate Ulcerative Colitis From Crohn's Disease? M Mahler, A Seaman, DP Bogdanos, P Pavlidis, Z Shums, A Forbes, ... Gastroenterology 140 (5), S-692, 2011
1 2011
P05 B-cell epitope mapping of anti-ro-52 responses in patients with primary biliary cirrhosis MG Mytilinaiou, W Meyer, L Komorowski, C Probst, E Davies, D Vergani, ... Gut 59 (Suppl 2), A13-A14, 2010
1 2010
S1191 Molecular Mimicry and Immunological Crossreactivity Between Measles Virus and Human Intestinal Proteins is Not a Feature of Crohn's Disease AL Koutsoumpas, D Polymeros, Z Tsiamoulos, G Karamanolis, ... Gastroenterology 138 (5), S-200, 2010
1 2010
678 DIAGNOSTIC AND CLINICAL APPLICATION OF A NEW LINE IMMUNOASSAY THAT SIMULTANEOUSLY DETECTS THE MULTIPLE NUCLEAR DOT SPECIFIC ANTIGENS IN PRIMARY BILIARY CIRRHOSIS M Mytilinaiou, W Meyer, A Janssen, P Pavlides, C Probst, NK Gatselis, ... Journal of Hepatology 50, S249, 2009
1 2009
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
45
676 FINE SPECIFICITY OF ANTI-NUP62 T-HELPER 1 CELL (TH1) IMMUNE RESPONSE IN PRIMARY BILIARY CIRRHOSIS F Meda, MS Longhi, DP Bogdanos, P Invernizzi, Y Ma, G Mieli-Vergani, ... Journal of Hepatology 50, S248, 2009
1 2009
869 ANALYSIS OF SPECIFIC AUTOANTIBODY PROFILES IN PRIMARY BILIARY LIVER CIRRHOSIS A Janssen, W Meyer, T Scheper, L Komorowski, C Probst, ... Journal of Hepatology 48, S326-S327, 2008
1 2008
[452] CHRONIC HEPATITIS C IS CHARACTERISED BY AN C Liaskos, DP Bogdanos, N Gatselis, M Homer, Z Shums, D Murphy, ... Journal of Hepatology 46, S172, 2007
1 2007
[670] A NEW SUBSTRATE FACILITATES THE DETECTION OF AUTOIMMUNE HEPATITIS SPECIFIC ANTI-SMOOTH MUSCLE ANTIBODIES DP Bogdanos, L Komorowski, C Liaskos, ET Davies, G Mieli-Vergani, ... Journal of Hepatology 46, S253-S254, 2007
1 2007
[25] IDENTIFICATION OF HLA-DR3 RESTRICTED CD4 T-CELL EPITOPES ON SOLUBLE LIVER ANTIGEN IN AUTOIMMUNE HEPATITIS TYPE 1 F Meda, P Wang, MS Longhi, DP Bogdanos, G Mieli-Vergani, D Vergani, ... Journal of Hepatology 46, S13, 2007
1 2007
Anti-chromatin antibodies identify patients with overlap primary biliary cirrhosis/autoimmune hepatitis syndrome. S Leoni, Z Shuns, DP Bogdanos, HM Smith, MA Heneghan, GL Norman, ... Hepatology 40 (4), 461A-461A, 2004
1 2004
P0294 HLA DR7 POSITIVE PATIENTS WITH TYPE 2 AUTOIMMUNE HEPATITIS ARE CHARACTERISED BY A PROLONGED CLINICAL COURSE J Underhill, DP Bogdanos, MS Longhi, S Bansal, G Mieli-Vergani, ... Journal of Pediatric Gastroenterology and Nutrition 39, S169, 2004
1 2004
Anti-SLA antibodies preferentially recognise conformational epitopes in autoimmune liver disease Y Ma, DP Bogdanos, R Williams, G Mieli-Vergani, D Verganil Journal of Hepatology 34, 210, 2001
1 2001
Thyroid peroxidase is a molecular mimicry target of anti-hepatitis C virus humoral response DP Bogdanos, M Lenzi, M Okamoto, Y Ma, P Aluigi, F Lari, L Muratori, ... Journal of Hepatology 32, 103, 2000
1 2000
Treatment with interferon-alpha unmasks cross-reactive immunity between hepatitis C virus and thyroid peroxidase, the major target antigen in thyroid ayutoimmunity. DP Bogdanos, M Lenzi, Y Ma, PAF Lari, L Muratori, R Williams, ... Hepatology 30 (4), 363A-363A, 1999
1 1999
ΔΠ ΜΠΟΓΔΑΝΟΣ, CV Νοέμβριος 2015
46
ENHANCED DETECTION AND CHARACTERIZATION OF PRIMARY BILIARY CIRRHOSIS PATIENTS WITH NEW M2 EP (MIT3), gp210, AND sp100 ELISA ASSAYS GL Norman, L Lee, Z Shums, DP Bogdanos, HJ Worman, EL Krawitt, ...
1
Bacterial Infections in Liver EI Rigopoulou, DS Smyk, T Orfanidou, DP Bogdanos, ME Gershwin Liver Immunology, 123-144, 2014
2014
Su1201 Diagnostic and Clinical Significance of the Pancreatic Autoantibodies Anti-GP2 and Anti-Cuzd1 in Inflammatory Bowel Diseases P Pavlidis, A Koutsoumpas, FA Sulttan, MG Mytilinaiou, A Forbes, ... Gastroenterology 5 (144), S-425-S-426, 2013
2013
Glycoprotein 2 Antibodies in Inflammatory Bowel Disease: No Association With Disease Phenotype? Response M Kovacs, G Veres JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 56 (1), E6-E6, 2013
2013
New sensitive technique for the detection of anti-smooth muscle antibodies in autoimmune hepatitis C Liaskos, MG Mytilinaiou, A Grammatikopoulos, DS Smyk, T Orfanidou, ... HEPATOLOGY 56, 991A-992A, 2012
2012